TSS:Hg 90675.1

Basic information about the TSS

---

TSS ID: hg_90675.1 Species: human Chr: chr8		Start: 127740604 End: 127740628 Strand: +
TSS cluster detected*

  * The number of TSS cluster called studies (maximum 16)

Gene and protein annotation

---

Transcript_name: X66258 Distance: 146 GeneID: 4609 HGNC/MGI_ID: HGNC:7553 UniProt_ID: Q6LBK7

Gene_name: MYC proto-oncogene, bHLH transcription factor Gene_symbol: MYC Gene_synonyms: MYCC bHLHe39 c-Myc Gene_source: HGNC:7553

TATA-Box annotation

---

Distance to TSS:	4385
Nearest PromoterID:	NM_002467
Entrez ID:	4609
Nearest Unigene:	Hs.202453
Nearest Refseq:	NM_002467
Nearest Ensembl:	ENSG00000136997
Gene Name:	MYC proto-oncogene, bHLH transcription factor
Gene Alias:	MRTL|MYCC|bHLHe39|c-Myc
Gene Description:	MYC proto-oncogene, bHLH transcription factor
Gene Type:	protein-coding
CpG%:	0.04
GC%:	0.572139
TATA-Box(TBP)/Promoter/Homer Distance From TSS(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@MYC p2@MYC p4@MYC p5@MYC p6@MYC p7@MYC p9@MYC p10@MYC
Sample		p1@MYC	p2@MYC	p4@MYC	p5@MYC	p6@MYC	p7@MYC	p9@MYC	p10@MYC
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	236.49	66.43	1.36	3.31	0.19	0.39	0.39	1.17
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	273.94	79.92	2.83	2.02	0.20	0.20	1.21	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	272.96	68.29	1.93	1.93	0.96	0.19	0.77	0.00
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	348.87	103.96	1.66	2.29	1.04	1.04	0.83	2.08
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	357.92	101.01	1.35	1.80	1.35	0.67	1.35	2.25
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	388.98	100.20	1.55	4.26	0.00	0.78	2.13	1.55
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	219.41	40.96	0.65	1.31	0.00	0.00	1.31	1.09
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	210.49	51.83	0.73	1.70	0.24	0.24	0.48	0.97
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	198.12	42.74	0.85	1.28	0.00	0.00	0.21	0.64
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	440.52	37.68	2.32	2.32	0.00	0.00	1.16	0.58
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	367.85	37.59	0.00	3.64	0.00	0.00	1.62	0.40
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	386.63	45.53	0.81	1.22	0.81	0.41	2.44	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	175.86	82.21	3.55	1.77	1.61	0.97	1.13	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	153.36	73.07	3.76	3.76	2.10	0.90	1.20	2.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	157.86	67.84	3.51	1.98	1.98	0.44	0.44	1.54
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	156.18	75.20	3.02	3.02	1.01	0.50	2.26	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	172.76	69.89	3.28	1.53	2.40	0.66	1.31	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	169.57	82.25	3.80	1.69	2.11	0.42	1.69	2.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	125.29	62.91	3.20	3.20	0.53	1.07	1.60	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	130.13	59.73	4.06	2.56	1.35	0.30	0.90	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	139.53	68.16	3.88	1.20	1.07	0.40	0.80	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	93.73	44.36	3.63	1.04	0.35	0.52	1.21	0.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	86.34	47.57	1.68	1.42	1.03	0.52	0.65	1.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	80.57	45.14	2.67	1.70	0.24	0.24	0.97	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	46.44	23.48	0.52	0.52	0.52	0.52	0.52	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	38.93	21.84	0.00	1.27	1.27	0.32	0.00	0.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	33.52	18.13	0.55	0.00	1.10	0.00	0.00	0.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	36.54	7.54	0.47	0.94	0.94	0.47	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	29.24	6.46	1.13	0.32	0.32	0.16	0.16	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	28.23	5.43	1.27	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	42.50	6.70	1.05	0.42	0.42	0.00	0.63	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	51.78	5.28	0.98	0.20	0.39	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	63.94	7.39	0.84	0.21	0.42	0.21	0.63	0.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	60.53	6.43	1.32	0.16	0.16	0.49	0.49	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	58.71	5.80	1.31	0.75	0.19	0.00	0.56	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	66.30	7.28	1.15	0.77	0.19	0.00	0.19	0.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	73.58	8.38	1.43	1.02	0.20	0.20	0.41	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	66.49	8.87	1.81	0.40	0.20	0.20	0.00	0.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	79.14	5.67	0.81	0.81	0.00	0.00	1.62	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	55.45	5.04	1.92	0.24	0.24	0.00	0.00	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	62.11	6.59	1.65	0.71	0.00	0.24	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	58.56	6.88	1.90	0.44	0.44	0.88	0.29	0.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	48.72	3.16	1.27	0.21	0.00	0.00	0.21	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	60.84	7.87	1.75	0.17	0.35	0.00	0.35	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	52.20	4.42	1.20	0.80	0.80	0.00	1.20	0.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	39.78	6.98	0.93	0.47	0.23	0.00	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	42.94	4.56	0.96	0.24	0.00	0.72	0.24	0.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	42.03	5.07	1.19	0.30	0.00	0.00	0.00	0.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	65.59	9.57	1.68	0.96	0.24	0.72	0.00	0.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	55.60	7.68	1.42	0.20	0.40	1.21	0.40	0.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	62.31	7.99	0.82	0.41	0.82	0.82	0.61	0.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	90.51	14.68	2.89	1.11	0.67	0.67	1.56	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	13.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	63.52	12.42	1.42	0.71	0.35	1.06	0.35	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	82.18	16.24	4.31	0.66	0.66	0.99	1.66	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	52.01	10.07	0.00	1.68	0.84	0.84	5.87	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	67.05	8.73	1.38	0.46	1.84	2.76	1.38	0.92
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	71.30	14.26	1.94	1.30	0.97	0.32	0.65	1.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	67.77	15.09	0.64	1.28	0.32	0.32	0.00	0.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	77.01	7.86	1.89	0.94	1.26	0.94	0.31	1.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	59.93	17.63	2.82	0.00	0.71	0.00	0.71	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	55.52	11.22	1.68	1.12	0.00	2.24	0.56	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	58.91	8.76	0.80	2.39	0.00	0.00	3.98	0.80
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	65.24	7.47	1.70	2.04	1.02	0.00	1.70	0.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	63.36	7.80	1.62	0.97	0.32	0.32	0.65	1.30
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	66.38	11.36	2.84	1.42	0.71	0.35	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	16.16	16.16	0.00	16.16	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	23.69	7.90	0.00	0.00	7.90	0.00	15.79	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	83.37	14.14	3.41	0.98	0.00	0.00	0.00	2.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	87.77	10.41	0.50	1.49	0.00	0.00	0.99	2.48
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	106.02	7.97	2.81	0.00	0.00	1.88	0.47	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	103.99	7.95	1.66	0.66	0.66	0.33	0.00	1.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	76.72	9.59	3.09	1.55	0.00	0.62	0.62	1.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	70.63	11.01	3.06	0.92	0.31	0.61	0.00	1.22
Adipocyte - breast, donor1	11376-118A8	64.30	19.48	3.64	0.48	0.00	0.16	0.48	0.16
Adipocyte - breast, donor2	11327-117E4	68.02	16.84	3.05	2.25	0.00	0.32	1.44	0.80
Adipocyte - omental, donor1	11473-119C6	65.27	18.32	3.44	0.51	0.25	0.38	0.25	0.38
Adipocyte - omental, donor2	11474-119C7	35.13	11.21	2.99	0.00	0.00	0.00	0.00	0.00
Adipocyte - omental, donor3	11475-119C8	48.90	8.37	2.01	0.00	0.00	0.33	0.33	0.33
Adipocyte - perirenal, donor1	11476-119C9	59.33	18.50	3.83	0.64	0.00	0.00	0.64	0.64
Adipocyte - subcutaneous, donor1	11259-116F8	54.98	23.09	0.00	1.10	0.00	0.00	1.10	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	138.20	180.65	2.26	6.32	4.97	4.97	2.26	1.35
Adipocyte - subcutaneous, donor3	11408-118E4	174.82	53.70	8.52	2.26	0.00	0.17	0.35	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	123.99	29.92	4.50	1.17	0.39	0.00	0.20	0.20
Adipocyte differentiation, day04, donor2	13022-139D7	144.13	48.39	1.80	1.80	0.51	0.26	0.00	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	109.00	15.61	1.95	0.56	0.28	0.28	0.28	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	131.67	20.57	1.18	1.18	0.59	1.18	0.00	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	57.51	7.40	5.47	0.56	0.16	0.00	0.08	0.80
Adipocyte differentiation, day08, donor2	13023-139D8	83.27	13.88	2.26	0.97	0.00	0.00	0.32	0.00
Adipocyte differentiation, day08, donor3	13026-139E2	110.90	11.20	0.53	1.60	0.00	0.53	0.53	1.60
Adipocyte differentiation, day08, donor4	13029-139E5	86.80	6.12	3.34	0.00	0.00	0.00	0.00	0.56
Adipocyte differentiation, day12, donor1	13021-139D6	47.41	5.41	1.66	0.42	0.00	0.00	0.00	0.00
Adipocyte differentiation, day12, donor2	13024-139D9	63.54	9.04	2.26	0.25	0.00	0.00	0.00	0.50
Adipocyte differentiation, day12, donor3	13027-139E3	61.19	10.80	2.95	0.65	0.00	0.00	0.33	0.00
Adipocyte differentiation, day12, donor4	13030-139E6	44.15	3.35	0.91	0.61	0.00	0.00	0.00	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	208.18	68.07	5.52	1.33	0.22	0.44	1.33	0.66
Alveolar Epithelial Cells, donor2	11590-120G6	229.13	55.94	5.02	1.43	1.08	1.08	1.08	0.72
Alveolar Epithelial Cells, donor3	11671-122G6	125.79	47.92	2.40	2.40	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	77.00	19.79	2.88	0.00	0.18	0.00	0.18	0.18
Amniotic Epithelial Cells, donor2	11613-122A2	45.18	11.71	1.67	0.00	0.00	0.00	0.00	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	65.13	13.56	3.90	1.03	0.21	0.21	0.21	0.21
Anulus Pulposus Cell, donor1	11248-116E6	90.17	28.84	1.60	1.26	0.46	0.23	0.23	0.34
Anulus Pulposus Cell, donor2	11463-119B5	84.00	28.65	2.69	0.00	0.00	0.24	0.24	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	42.68	8.99	2.70	1.35	0.45	0.45	0.90	0.45
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	57.31	11.72	5.64	1.30	0.87	1.30	0.87	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	32.10	6.42	0.00	0.00	0.00	2.14	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	47.83	11.06	2.09	0.90	0.60	0.30	0.90	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	37.94	17.71	0.00	2.53	0.00	1.26	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	43.56	9.90	1.98	0.00	0.00	0.00	1.32	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	51.98	7.47	0.65	0.32	0.97	0.65	0.32	0.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	55.34	12.62	2.91	1.94	0.49	0.00	0.49	0.97
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	39.79	11.28	0.59	0.00	1.19	0.59	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	47.08	9.79	1.88	0.38	0.38	0.38	0.38	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	52.25	13.79	4.35	1.45	2.18	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	45.14	7.52	0.00	1.25	0.00	2.51	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	38.38	9.55	2.14	0.66	0.49	0.82	0.00	0.49
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	39.58	6.82	1.36	0.00	1.36	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	35.13	4.83	2.41	0.45	0.60	0.75	0.00	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	38.58	10.18	2.14	1.07	0.54	0.00	0.54	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	36.09	6.80	1.70	0.76	0.00	0.57	0.38	0.38
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	40.89	8.55	1.07	0.27	0.27	1.87	0.00	0.27
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	41.94	12.68	1.95	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	36.65	12.11	2.82	0.66	0.50	0.50	0.33	0.50
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	44.43	8.41	1.20	1.20	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	42.48	3.54	3.54	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	48.20	10.12	2.92	0.51	0.17	0.51	0.00	0.34
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	62.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	42.23	9.71	3.88	0.00	1.46	0.97	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	35.67	13.66	2.66	0.38	1.14	0.38	0.00	0.38
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	31.50	6.06	1.21	0.00	0.00	1.21	0.00	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	49.59	10.83	0.57	0.57	0.57	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	42.33	11.54	1.71	0.43	0.43	0.43	0.21	0.00
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	35.36	7.74	2.32	0.26	0.77	0.00	0.00	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	50.67	10.32	2.35	0.94	0.47	0.00	0.94	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	49.52	12.86	1.61	0.64	0.32	0.32	0.32	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	40.67	7.13	1.43	1.43	0.00	0.71	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	44.46	11.70	2.34	1.17	0.00	1.17	0.00	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	44.26	12.34	0.60	0.90	0.30	1.81	0.00	0.60
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	54.65	8.32	3.56	2.38	0.00	1.19	1.19	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	51.36	12.71	1.53	1.02	0.51	0.51	1.02	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	44.32	10.44	1.27	0.76	0.51	1.02	1.27	0.25
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	50.83	11.44	1.91	1.27	0.00	0.00	0.64	0.00
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	41.43	11.65	1.29	1.29	0.00	0.86	0.43	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	36.41	11.01	1.69	0.21	0.64	0.64	0.00	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	33.93	10.73	0.29	0.00	0.87	0.00	0.29	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	28.34	7.56	0.94	0.00	1.89	0.94	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	41.70	10.00	2.03	0.51	0.51	0.34	0.17	0.51
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	32.43	2.32	0.00	2.32	0.00	2.32	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	48.59	8.45	2.11	0.00	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	31.52	8.36	1.93	0.86	0.64	0.64	0.21	0.21
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	25.87	4.81	1.80	1.80	0.00	0.00	1.20	0.60
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	40.09	10.93	2.19	0.00	0.00	0.00	0.73	0.00
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	42.07	7.82	1.84	0.46	0.46	0.23	0.23	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	51.01	12.75	0.00	2.55	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	30.00	8.64	0.76	0.00	1.02	0.76	0.51	0.25
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	38.40	9.70	1.65	1.03	0.83	0.83	0.00	0.21
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	36.41	11.93	2.45	0.61	0.61	0.31	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	44.93	8.60	1.43	1.91	0.96	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	40.13	7.54	3.10	0.22	0.44	1.33	0.00	0.22
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	28.99	10.68	0.00	0.00	0.00	0.00	0.00	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	40.99	6.65	1.66	1.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	38.13	10.59	1.59	0.53	1.06	0.26	0.26	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	32.35	7.63	1.45	0.00	0.36	0.36	0.36	0.36
Astrocyte - cerebellum, donor1	11500-119F6	133.87	46.18	5.90	0.74	0.61	0.37	0.25	0.25
Astrocyte - cerebellum, donor2	11580-120F5	118.61	46.90	4.79	0.17	0.17	0.17	0.86	0.34
Astrocyte - cerebellum, donor3	11661-122F5	89.77	35.66	5.87	0.21	0.00	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	31.02	11.50	3.14	0.00	0.00	0.00	0.00	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	39.96	15.21	2.26	0.65	0.00	0.16	0.32	0.16
Astrocyte - cerebral cortex, donor3	11392-118C6	68.91	27.00	2.98	0.75	0.00	0.00	0.00	0.15
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	363.90	53.90	1.61	1.72	5.50	2.41	1.61	1.72
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	406.66	52.87	1.50	2.76	4.64	2.38	0.75	1.13
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	347.99	43.58	0.57	1.59	3.64	2.96	0.68	0.57
Basophils, donor1	12241-129G9	12.03	1.31	1.31	0.26	0.78	0.52	0.26	0.26
Basophils, donor2	12242-129H1	13.35	1.80	1.80	0.00	0.36	0.00	0.36	0.00
Basophils, donor3	12243-129H2	21.76	2.50	1.18	0.29	0.15	0.00	0.15	0.29
Bronchial Epithelial Cell, donor1	11511-119G8	260.45	322.97	3.02	2.37	3.23	1.51	2.16	0.43
Bronchial Epithelial Cell, donor2	11591-120G7	250.99	133.04	0.91	1.83	4.11	3.66	0.00	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	552.36	179.34	0.00	7.17	21.52	0.00	7.17	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	200.85	190.81	1.88	2.51	8.16	3.77	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	264.10	173.22	2.29	0.62	3.74	2.50	1.04	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	210.49	104.32	0.69	1.61	1.84	2.30	1.15	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	228.17	147.73	3.24	3.24	6.30	2.16	2.88	1.44
Burkitt's lymphoma cell line:DAUDI	10422-106C8	341.53	365.33	0.00	1.34	2.68	0.31	0.93	0.82
Burkitt's lymphoma cell line:RAJI	10476-106I8	165.36	444.15	0.70	1.40	4.43	2.56	3.73	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	96.25	144.54	2.56	0.32	0.96	1.92	0.00	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	0.00	20.68	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	63.68	3.94	2.25	1.13	0.56	0.00	0.56	0.56
CD14+ Monocytes, donor2	11305-117B9	109.50	4.64	9.84	3.34	1.48	0.37	1.30	0.74
CD14+ Monocytes, donor3	11381-118B4	38.42	2.41	2.85	1.54	0.66	0.44	0.22	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	5.09	1.42	2.83	3.68	0.00	0.00	0.00	0.57
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	17.06	4.93	3.79	1.14	0.76	0.00	0.38	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	11.83	2.63	3.62	3.29	0.00	0.00	0.33	0.00
CD14+ monocytes - mock treated, donor1	11863-125A9	16.04	1.45	2.17	2.17	0.00	0.00	0.29	0.43
CD14+ monocytes - mock treated, donor2	11873-125C1	19.31	2.72	1.81	1.81	0.30	0.00	0.00	0.00
CD14+ monocytes - mock treated, donor3	11883-125D2	21.32	3.32	1.90	3.08	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	39.51	2.68	2.01	2.18	0.17	0.17	0.17	0.50
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	43.89	4.14	1.66	2.21	0.00	0.28	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	56.53	6.45	2.73	1.49	0.25	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor1	11860-125A6	13.51	2.35	1.37	0.39	0.00	0.00	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	13.53	1.25	0.18	0.71	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with BCG, donor3	11880-125C8	12.84	1.74	0.00	0.22	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Candida, donor1	11868-125B5	101.85	9.13	1.40	0.94	0.00	0.00	0.70	0.47
CD14+ monocytes - treated with Candida, donor2	11878-125C6	130.95	15.31	2.64	2.11	0.00	0.00	3.17	2.11
CD14+ monocytes - treated with Candida, donor3	11888-125D7	117.59	6.66	1.11	1.11	0.00	0.00	1.11	1.11
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	21.87	2.23	1.19	1.93	0.00	0.00	0.30	0.45
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	26.94	4.99	1.60	1.60	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	37.06	5.62	1.87	1.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	68.41	4.35	0.69	0.92	0.46	0.00	0.69	0.92
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	74.42	9.05	2.04	0.45	0.00	0.23	0.45	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	71.58	6.11	0.87	0.87	0.00	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	13.99	2.42	1.61	1.08	0.27	0.00	0.00	0.27
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	17.10	1.74	0.87	0.35	0.00	0.00	0.17	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	12.20	3.37	0.00	0.84	0.00	0.00	0.42	0.42
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	105.27	7.72	4.96	1.84	0.00	0.00	0.73	0.18
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	168.03	15.85	1.76	3.17	0.00	0.35	0.35	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	180.32	18.43	6.14	4.39	0.44	0.00	0.88	0.44
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	23.54	2.62	1.05	0.17	0.17	0.00	0.17	0.00
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	18.21	4.09	0.74	0.37	0.00	0.00	0.00	0.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	13.58	2.16	0.22	0.65	0.00	0.00	0.22	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	74.12	8.19	2.46	1.64	0.00	0.00	0.00	0.82
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	124.01	10.43	3.48	1.16	0.46	0.23	0.70	0.93
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	106.25	12.53	2.78	2.32	0.00	0.00	0.23	0.93
CD14+CD16+ Monocytes, donor1	11789-124B7	1.74	0.44	0.65	0.22	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	0.92	0.69	0.00	0.46	0.23	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	0.65	0.87	0.43	0.43	0.22	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	2.80	0.93	1.25	0.62	0.00	0.00	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	3.84	0.70	1.22	0.87	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	2.90	1.34	1.11	1.11	0.00	0.00	0.00	0.45
CD14-CD16+ Monocytes, donor1	11790-124B8	1.53	0.26	1.02	2.04	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor2	11800-124C9	1.98	0.88	0.00	0.44	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	1.26	0.63	0.42	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	63.00	34.55	2.03	2.03	4.06	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.75	29.15	2.03	4.07	2.71	0.00	0.00	0.68
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	54.89	26.93	4.14	5.18	4.14	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	59.70	35.71	4.26	3.20	3.20	1.60	0.53	0.00
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	62.18	29.48	5.90	3.22	5.36	1.07	0.00	0.54
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	73.70	35.10	3.51	4.21	1.40	0.70	0.00	0.70
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	50.98	26.67	4.71	4.71	3.14	0.78	0.78	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	63.28	32.96	2.64	9.23	2.64	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	246.57	38.63	9.04	9.04	4.93	0.00	0.82	0.82
CD19+ B Cells, donor2	11624-122B4	187.89	31.92	4.35	5.80	2.18	0.00	0.73	0.73
CD19+ B Cells, donor3	11705-123B4	253.42	38.87	2.52	7.57	3.03	0.00	2.02	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	127.68	17.37	1.21	0.40	0.00	0.81	0.40	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	97.08	16.78	0.80	0.40	0.40	0.00	0.40	0.00
CD34+ Progenitors, donor1	11545-120B6	26.11	19.08	0.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	116.29	16.85	2.25	0.00	2.81	1.12	0.56	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	151.81	324.28	3.38	1.50	1.50	1.13	1.50	1.50
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	180.16	289.75	2.71	2.48	1.80	2.25	0.68	1.58
CD4+ T Cells, donor1	11225-116C1	160.68	23.21	3.93	1.07	5.36	3.21	1.79	0.36
CD4+ T Cells, donor2	11306-117C1	172.69	13.47	1.84	2.45	6.74	3.06	0.61	0.61
CD4+ T Cells, donor3	11382-118B5	134.50	17.08	4.27	0.91	3.96	1.83	1.22	0.30
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	184.28	58.45	7.66	2.30	1.53	0.26	0.77	2.81
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	228.19	77.49	11.45	1.80	1.12	0.90	0.22	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	158.97	64.68	10.06	2.59	1.44	0.57	0.29	0.29
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	120.89	65.90	3.32	1.90	3.32	0.00	0.95	0.00
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	210.70	66.02	3.51	2.11	3.51	0.70	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	280.18	98.89	0.00	3.30	6.59	6.59	0.00	3.30
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	64.45	14.89	1.16	1.30	1.30	0.29	0.14	0.43
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	83.38	18.30	4.74	1.36	0.34	0.17	0.68	0.17
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	63.19	11.77	2.58	0.81	0.32	0.16	0.32	0.97
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	77.11	22.86	1.79	2.24	2.24	0.90	0.45	1.34
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	99.58	31.44	4.19	2.45	2.80	1.05	0.35	1.75
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	67.76	26.84	2.20	1.76	0.88	0.44	0.88	1.32
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	149.26	24.88	5.06	1.69	2.11	0.84	1.69	1.26
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	102.22	16.83	3.32	2.91	0.42	1.04	0.42	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	96.90	14.03	1.67	1.00	0.67	1.00	0.00	0.33
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	188.72	91.64	5.98	2.72	1.63	0.54	1.09	1.90
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	306.56	88.97	4.82	0.54	2.68	1.07	0.54	1.61
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	276.16	73.52	7.17	3.59	0.00	0.00	3.59	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	212.13	32.64	3.89	1.85	1.48	0.74	1.11	1.30
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	163.11	32.28	3.68	1.95	0.43	0.43	0.43	0.22
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	125.04	25.85	2.73	1.05	1.05	0.21	0.42	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	123.87	26.80	5.56	4.04	3.54	2.02	0.51	0.00
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	110.91	23.40	2.60	0.00	1.73	0.43	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	138.15	26.15	3.49	2.61	0.44	0.00	0.87	0.44
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	253.37	76.70	8.41	3.96	1.98	1.48	0.49	0.49
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	161.56	59.08	12.92	2.77	6.46	0.00	2.77	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	159.12	71.19	2.79	2.79	2.79	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	252.84	79.76	5.26	2.77	0.55	0.55	1.11	1.11
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	287.11	92.51	10.06	2.70	3.44	0.74	1.47	1.96
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	204.82	61.60	6.16	1.54	1.54	0.00	0.00	1.54
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	202.69	64.10	7.16	1.07	1.43	0.72	0.36	0.72
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	162.04	62.32	1.38	0.00	0.00	1.38	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	92.98	10.80	0.33	1.64	7.20	2.29	0.98	0.65
CD8+ T Cells, donor2	11307-117C2	91.61	1.50	0.75	1.88	6.76	2.25	0.75	0.75
CD8+ T Cells, donor3	11383-118B6	104.03	15.65	1.77	1.51	4.54	0.76	0.76	0.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	191.08	50.70	2.29	0.92	0.23	1.38	0.69	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	184.52	59.19	0.72	2.16	0.24	0.96	0.72	0.24
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	174.28	56.63	0.55	3.28	0.27	3.28	0.55	0.27
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	222.76	52.84	1.20	1.80	0.60	2.40	0.90	0.90
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	267.82	72.95	0.72	2.40	0.48	1.68	0.24	1.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	240.35	62.30	1.14	1.36	0.91	1.14	0.45	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	127.11	27.16	0.87	0.43	0.00	0.87	0.00	0.43
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	135.55	31.06	0.79	0.79	0.26	0.26	0.00	1.05
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	132.97	29.78	0.94	1.88	0.70	1.88	0.70	1.17
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	176.30	56.75	1.21	2.42	0.00	0.60	0.60	0.00
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	164.14	54.32	0.58	1.16	0.00	0.87	0.29	1.74
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	170.52	52.75	2.40	1.60	0.27	2.13	0.53	1.07
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	120.82	81.86	0.88	0.44	2.63	0.44	0.44	0.88
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	107.94	73.78	0.91	0.91	0.91	5.01	0.00	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	111.88	61.16	0.75	0.00	0.75	1.49	0.00	0.75
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	269.40	74.19	2.88	2.16	0.00	2.16	1.08	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	239.96	66.46	2.88	1.44	0.29	1.73	0.58	1.15
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	207.88	64.11	2.36	1.89	0.47	2.36	1.18	0.47
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	161.30	31.37	0.95	1.27	0.63	0.63	0.63	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	154.09	30.14	0.00	1.54	0.00	0.31	0.62	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	150.67	31.74	0.96	0.32	0.32	0.64	0.00	0.64
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	193.15	51.63	0.76	1.53	0.38	1.15	0.76	1.91
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	195.87	47.29	0.00	1.18	0.39	1.58	1.97	0.79
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	195.91	55.22	1.51	1.51	0.00	2.27	2.27	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	140.52	81.90	1.61	1.61	2.41	1.61	0.00	0.80
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	146.18	74.14	0.00	0.00	4.20	6.29	0.00	0.70
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	174.30	75.13	2.00	2.00	3.01	8.01	1.00	0.00
Cardiac Myocyte, donor1	11525-119I4	96.87	25.59	1.83	1.83	0.00	0.00	0.00	0.00
Cardiac Myocyte, donor2	11605-120I3	75.10	32.12	4.45	0.99	0.49	0.49	0.99	0.49
Cardiac Myocyte, donor3	11686-122I3	139.12	85.76	12.73	1.05	0.42	0.53	0.21	0.42
Chondrocyte - de diff, donor1	11261-116G1	65.17	16.29	3.47	1.04	0.00	0.00	0.35	0.35
Chondrocyte - de diff, donor2	11338-117F6	60.41	9.95	3.20	0.36	0.00	0.36	0.36	0.36
Chondrocyte - de diff, donor3	11410-118E6	42.55	6.83	1.37	0.57	0.00	0.00	0.00	0.23
Chondrocyte - re diff, donor2	11339-117F7	51.92	4.48	0.90	0.00	0.00	0.00	0.00	0.90
Chondrocyte - re diff, donor3	11411-118E7	56.21	4.85	0.00	0.00	0.00	0.40	0.00	0.00
Ciliary Epithelial Cells, donor1	11242-116D9	97.43	32.48	3.67	0.46	0.34	0.34	0.57	0.46
Ciliary Epithelial Cells, donor2	11323-117D9	74.18	29.93	2.78	1.07	0.21	0.86	0.86	0.64
Ciliary Epithelial Cells, donor3	11399-118D4	94.87	40.80	4.25	1.59	0.53	0.62	0.09	0.35
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	58.50	5.69	1.93	0.46	0.00	0.09	0.09	0.28
Corneal Epithelial Cells, donor1	11526-119I5	312.01	202.01	2.20	0.88	3.95	2.20	1.76	0.22
Corneal Epithelial Cells, donor2	11606-120I4	240.03	102.38	2.28	1.14	2.28	0.00	1.14	1.14
Corneal Epithelial Cells, donor3	11687-122I4	238.76	98.42	1.79	1.02	1.79	1.28	1.02	1.28
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	25.26	3.63	1.32	1.32	0.00	0.00	0.33	0.17
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	20.82	4.73	1.26	1.58	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	27.61	3.45	0.00	3.45	0.00	0.00	0.00	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	37.47	4.97	2.38	0.86	0.11	0.00	0.11	0.32
Dendritic Cells - plasmacytoid, donor1	11228-116C4	11.62	0.34	0.34	0.68	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	1.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	5.81	0.00	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	115.57	53.37	7.84	0.67	0.83	0.33	0.33	0.33
Endothelial Cells - Aortic, donor1	11263-116G3	106.21	73.35	4.69	0.59	0.59	0.00	0.59	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	139.98	60.52	8.20	1.41	0.57	0.28	0.28	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	103.01	53.87	5.90	1.57	0.00	0.39	0.00	0.00
Endothelial Cells - Artery, donor1	11264-116G4	111.40	60.79	9.60	0.87	0.87	1.16	0.58	0.58
Endothelial Cells - Artery, donor2	11341-117F9	148.46	106.82	6.59	2.35	0.71	0.71	1.18	1.18
Endothelial Cells - Artery, donor3	11413-118E9	145.16	59.78	6.49	0.88	1.40	0.53	0.53	1.23
Endothelial Cells - Lymphatic, donor1	11236-116D3	64.72	36.13	6.43	1.77	0.22	0.22	0.44	0.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	70.59	32.56	7.61	0.91	0.61	0.00	0.30	1.52
Endothelial Cells - Lymphatic, donor3	11393-118C7	85.42	23.40	9.58	0.85	0.00	0.28	0.28	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	101.62	51.11	7.73	0.30	0.59	0.30	0.89	0.89
Endothelial Cells - Microvascular, donor2	11342-117G1	78.10	55.71	3.64	2.08	0.00	2.08	1.04	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	110.31	65.22	10.21	1.42	0.14	0.00	1.13	0.99
Endothelial Cells - Thoracic, donor1	11266-116G6	124.84	62.82	9.60	0.80	0.40	0.00	1.60	0.40
Endothelial Cells - Thoracic, donor2	11343-117G2	145.18	61.32	10.48	3.14	1.05	1.05	0.52	1.05
Endothelial Cells - Umbilical vein, donor1	11243-116E1	142.39	39.76	8.45	0.87	0.75	0.50	0.75	1.37
Endothelial Cells - Umbilical vein, donor2	11324-117E1	106.68	26.29	5.00	0.22	0.22	0.00	0.43	0.22
Endothelial Cells - Umbilical vein, donor3	11400-118D5	130.19	29.80	1.71	0.73	0.24	0.61	0.12	0.24
Endothelial Cells - Vein, donor1	11267-116G7	91.00	34.13	2.28	1.14	1.14	0.00	0.00	1.14
Endothelial Cells - Vein, donor2	11344-117G3	139.70	44.70	7.68	0.00	0.70	0.00	0.70	1.40
Endothelial Cells - Vein, donor3	11416-118F3	88.71	42.86	6.75	0.63	0.31	0.16	0.00	0.00
Eosinophils, donor1	12244-129H3	30.49	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	13.20	1.65	1.65	0.00	1.65	0.00	0.00	0.00
Eosinophils, donor3	12246-129H5	35.67	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	224.54	261.67	2.20	2.44	2.93	1.71	0.98	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	361.95	289.14	4.16	4.16	2.08	0.00	2.08	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	357.91	211.49	0.00	0.00	16.27	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	63.63	8.21	3.28	1.23	0.82	0.00	0.00	0.41
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	42.92	14.12	3.39	1.97	0.00	0.11	0.88	0.88
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	66.30	33.48	3.58	1.30	0.54	0.22	0.98	0.54
Fibroblast - Aortic Adventitial, donor1	11245-116E3	91.45	47.18	5.22	0.97	0.24	1.21	0.61	1.46
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	184.92	45.31	7.37	3.68	2.05	1.77	0.55	0.55
Fibroblast - Aortic Adventitial, donor2	11326-117E3	68.45	18.88	3.06	1.27	0.21	0.53	0.32	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	232.40	64.56	7.11	2.63	2.11	1.32	0.79	0.79
Fibroblast - Aortic Adventitial, donor3	11401-118D6	100.66	29.57	6.31	1.00	0.00	1.33	0.66	1.33
Fibroblast - Cardiac, donor1	11268-116G8	92.09	35.84	7.26	0.91	0.00	0.45	0.91	0.45
Fibroblast - Cardiac, donor2	11345-117G4	127.34	53.06	4.55	3.03	2.27	3.79	0.76	0.76
Fibroblast - Cardiac, donor3	11417-118F4	65.61	26.65	4.10	0.79	0.32	0.47	0.47	0.00
Fibroblast - Cardiac, donor4	11452-119A3	76.38	33.95	6.67	0.30	0.00	0.30	0.00	0.30
Fibroblast - Cardiac, donor5	11456-119A7	92.77	51.40	5.71	0.89	0.13	0.51	0.63	0.51
Fibroblast - Cardiac, donor6	11460-119B2	77.62	39.57	5.31	1.06	0.30	0.30	0.45	0.61
Fibroblast - Choroid Plexus, donor1	11492-119E7	104.65	43.14	5.90	0.67	0.27	0.67	0.27	0.00
Fibroblast - Choroid Plexus, donor2	11572-120E6	90.17	38.40	3.02	1.29	0.43	3.02	0.43	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	234.37	101.07	14.65	4.39	1.46	0.00	1.46	4.39
Fibroblast - Conjunctival, donor1	11531-120A1	313.44	131.69	6.92	0.92	0.46	0.23	0.92	0.23
Fibroblast - Conjunctival, donor3	11692-122I9	86.67	94.81	5.09	0.85	0.17	0.34	0.51	0.34
Fibroblast - Dermal, donor1	11269-116G9	199.80	236.19	1.88	4.46	3.76	3.52	1.17	1.41
Fibroblast - Dermal, donor2	11346-117G5	202.35	203.29	2.36	1.89	5.19	3.77	0.94	0.00
Fibroblast - Dermal, donor3	11418-118F5	186.16	217.84	3.02	3.02	1.33	1.69	1.45	1.33
Fibroblast - Dermal, donor4	11450-119A1	196.59	117.23	1.92	2.49	0.79	0.57	0.34	1.92
Fibroblast - Dermal, donor5	11454-119A5	170.96	103.63	2.62	0.70	1.40	1.05	0.35	1.22
Fibroblast - Dermal, donor6	11458-119A9	204.00	98.59	2.27	2.27	1.95	1.79	0.65	1.46
Fibroblast - Gingival, donor1	11237-116D4	102.66	94.54	3.12	0.42	0.42	0.21	0.42	0.42
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	46.11	7.07	1.83	0.52	0.00	0.00	0.26	0.00
Fibroblast - Gingival, donor2	11318-117D4	99.10	33.47	4.35	0.53	0.13	0.00	0.79	0.53
Fibroblast - Gingival, donor3	11394-118C8	99.01	55.01	2.80	1.35	0.10	0.39	0.19	0.68
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	37.40	12.47	1.04	0.00	0.00	0.00	0.00	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	38.06	5.29	1.59	0.88	0.18	0.18	0.00	0.88
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	53.78	4.37	1.40	0.47	0.00	0.31	0.00	0.00
Fibroblast - Gingival, donor6 (control)	11922-125H5	72.35	10.82	2.03	0.68	0.00	0.00	0.14	0.14
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	92.81	16.23	7.76	1.41	0.71	0.00	0.35	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	61.72	8.63	2.78	0.29	0.15	0.00	0.29	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	47.72	3.95	1.36	0.14	0.14	0.00	0.14	0.27
Fibroblast - Gingival, donor8 (control)	11926-125H9	122.42	18.98	2.52	0.44	0.22	0.66	0.22	0.22
Fibroblast - Gingival, donor9 (control)	11927-125I1	24.36	2.93	1.17	0.73	0.00	0.00	0.44	0.44
Fibroblast - Lung, donor1	11270-116H1	179.43	100.59	0.00	0.00	4.08	0.00	0.00	0.00
Fibroblast - Lung, donor2	11347-117G6	155.18	73.12	4.48	0.00	1.49	0.00	0.00	1.49
Fibroblast - Lung, donor3	11419-118F6	151.52	98.98	4.64	1.48	0.21	0.42	1.69	0.42
Fibroblast - Lymphatic, donor1	11506-119G3	459.83	156.61	5.83	0.83	0.00	0.83	0.83	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	96.51	93.71	11.19	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	164.01	57.09	7.00	1.40	0.00	1.40	0.56	0.00
Fibroblast - Mammary, donor1	11540-120B1	344.26	303.26	6.50	4.06	1.62	2.03	0.81	0.00
Fibroblast - Mammary, donor2	11620-122A9	343.50	123.82	0.00	3.99	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	220.38	95.30	5.96	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	89.23	41.32	1.16	0.58	0.00	0.39	0.19	0.19
Fibroblast - Periodontal Ligament, donor2	11319-117D5	146.68	56.43	3.34	1.97	0.15	0.30	0.91	0.61
Fibroblast - Periodontal Ligament, donor3	11395-118C9	138.61	68.24	7.34	0.00	0.31	0.61	0.00	0.61
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	65.26	11.45	2.29	0.38	0.00	0.00	0.38	0.00
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	37.80	4.05	2.97	1.08	0.00	0.27	0.00	0.54
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	36.76	4.75	1.62	0.35	0.12	0.00	0.12	0.46
Fibroblast - Pulmonary Artery, donor1	11250-116E8	85.33	46.76	4.20	0.55	0.11	0.33	0.55	0.11
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	137.56	27.02	5.89	0.61	0.20	0.20	0.41	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	171.06	90.88	3.34	1.34	0.67	0.00	0.00	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	129.28	120.59	3.16	1.19	0.79	0.40	0.79	1.58
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	138.52	11.11	2.98	0.79	0.20	0.40	0.40	0.20
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	60.92	17.05	1.24	0.18	0.18	0.53	0.53	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	88.10	26.80	1.38	1.18	0.00	0.00	0.20	0.79
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	103.49	10.23	3.91	0.90	0.30	0.30	0.00	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	53.11	13.82	2.70	0.43	0.22	0.22	0.54	0.22
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	149.82	16.20	2.28	1.01	1.52	1.01	0.51	0.00
Fibroblast - skin normal, donor1	11553-120C5	50.86	9.19	1.48	0.16	0.16	0.00	0.33	0.49
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	134.94	17.04	3.01	0.60	0.20	1.20	0.00	0.00
Fibroblast - skin normal, donor2	11561-120D4	62.69	12.06	1.81	1.11	0.10	0.40	0.30	0.10
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	152.63	15.41	2.12	0.60	0.30	0.30	0.00	0.00
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	54.43	15.16	2.32	0.50	0.17	0.25	0.17	0.08
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	38.46	9.74	1.03	0.85	0.34	0.34	0.34	0.68
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	121.85	9.85	3.28	0.99	0.66	0.00	0.66	0.66
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	36.11	6.50	2.13	0.32	0.11	0.00	0.00	0.11
Fibroblast - skin walker warburg, donor1	11554-120C6	54.32	11.30	3.20	1.18	0.34	0.00	0.00	0.00
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	30.74	5.80	0.94	0.31	0.16	0.16	0.47	0.31
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	66.48	22.16	0.00	0.00	22.16	0.00	0.00	0.00
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	417.46	60.14	11.33	4.36	0.00	0.00	3.49	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	76.28	34.50	2.43	0.00	0.87	0.35	0.69	0.69
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	91.87	58.81	2.34	0.78	1.30	1.04	0.52	0.78
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	114.47	82.02	3.32	1.02	2.81	2.56	0.26	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	71.96	41.34	0.77	0.00	0.77	0.00	1.53	1.53
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	95.07	44.67	3.19	0.64	0.00	0.00	2.55	2.55
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	98.13	21.11	2.00	0.86	0.57	0.29	0.57	0.57
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	23.44	9.38	1.65	0.28	0.00	0.00	0.55	0.55
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	42.70	9.36	1.60	0.91	0.23	0.00	0.23	0.91
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	74.89	20.80	2.38	0.59	0.40	0.00	0.59	0.99
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	29.34	5.02	1.85	0.26	0.00	0.00	0.00	0.79
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	32.61	8.81	0.65	0.00	0.33	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	92.42	20.78	2.21	0.44	0.00	0.00	0.88	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	50.45	25.72	2.54	0.57	0.00	0.00	0.42	0.42
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	38.67	14.16	2.46	0.74	0.00	0.00	0.37	0.25
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	56.95	22.03	0.81	1.07	0.00	0.00	1.34	0.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	63.31	47.08	4.83	0.74	0.25	0.00	0.87	0.50
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	95.93	62.15	5.54	0.14	0.42	0.00	0.14	0.28
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	70.95	41.47	5.08	0.61	0.81	0.00	1.63	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	29.66	25.10	2.28	0.00	0.68	0.00	0.23	0.46
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	38.49	31.64	2.99	1.12	0.37	0.00	0.12	0.50
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	53.33	38.47	4.59	0.87	0.00	0.00	1.09	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	28.07	23.34	2.07	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	21.78	15.42	1.91	0.16	0.16	0.00	0.16	0.00
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	21.45	10.05	2.01	0.89	0.22	0.00	2.01	1.34
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	40.73	36.90	1.61	1.21	0.00	0.20	0.20	0.81
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	32.23	16.29	2.21	0.68	0.68	0.34	0.17	0.17
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	34.58	31.57	2.57	1.15	0.27	0.09	0.71	0.27
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	83.35	98.02	4.06	1.25	0.62	1.46	0.31	0.73
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	94.78	98.54	2.05	0.51	1.20	0.51	0.68	0.17
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	52.56	44.59	2.66	1.00	1.00	0.11	0.22	0.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	39.60	39.10	2.33	3.41	0.58	0.08	4.58	2.33
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	48.60	45.12	2.86	4.29	0.20	0.41	6.33	2.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	42.50	41.47	1.44	1.03	0.41	0.21	0.21	0.41
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	38.39	34.01	1.96	0.58	0.69	0.46	0.23	0.81
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	81.55	76.21	3.34	5.17	1.00	1.00	10.67	4.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	59.30	64.81	1.54	1.32	0.22	0.22	0.22	0.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	70.35	54.61	2.83	1.11	0.37	0.86	0.98	1.23
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	45.87	45.55	1.62	2.76	0.32	0.49	2.76	1.95
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	67.67	65.11	1.92	1.28	1.28	1.92	0.00	0.96
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	62.35	47.38	3.03	0.57	0.28	0.66	0.76	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	90.63	105.35	4.59	1.74	0.95	0.47	0.63	1.42
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	66.29	28.58	2.13	0.30	0.00	0.30	0.30	0.91
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	57.81	40.87	3.24	0.42	0.31	0.52	0.52	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	82.55	97.92	3.07	5.05	1.54	1.32	4.17	3.29
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	48.53	37.87	3.65	0.56	0.28	0.28	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	83.98	46.94	3.24	1.20	0.28	0.56	0.74	1.57
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	94.66	76.48	3.21	1.07	0.53	1.60	1.34	0.53
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	92.11	45.60	3.37	1.22	1.68	0.92	0.15	0.61
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	68.27	37.44	3.50	5.44	1.81	0.26	6.74	2.72
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	81.86	63.97	2.98	4.07	0.27	0.54	1.08	2.71
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	69.13	62.31	6.08	1.29	0.55	0.92	1.11	0.37
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	71.06	61.41	3.95	2.19	1.54	0.00	1.32	0.88
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	66.45	36.69	4.96	1.98	0.00	1.98	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	51.97	25.46	2.90	0.53	0.53	0.53	0.13	0.13
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	51.65	25.62	2.22	1.41	0.61	0.20	0.81	0.40
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	45.49	22.62	1.78	0.76	0.00	1.27	1.52	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	51.36	23.49	2.19	0.20	0.00	0.00	0.80	0.40
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	54.70	23.27	1.54	1.23	0.15	0.00	1.69	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	52.58	14.53	0.82	1.02	0.00	0.00	1.23	0.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	34.74	17.52	2.82	0.00	0.00	0.00	0.63	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	38.43	17.24	1.98	0.00	0.00	0.00	0.28	1.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	29.06	7.84	0.00	0.46	0.46	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	22.27	44.55	2.47	0.00	0.00	0.00	0.00	2.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	28.62	20.89	2.32	1.93	0.00	0.00	0.39	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	41.72	14.44	3.21	1.60	0.00	0.00	0.00	1.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	19.13	20.87	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	24.41	15.62	2.28	0.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	20.59	18.12	0.41	1.24	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	23.33	16.66	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	10.91	16.50	0.28	0.84	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	16.02	17.00	0.33	0.33	0.00	0.00	0.65	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	12.58	11.74	0.84	0.00	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	12.09	7.00	0.00	0.00	0.00	0.00	0.32	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	13.59	9.85	0.00	0.00	0.68	0.00	0.34	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	10.44	4.18	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	9.16	5.15	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	9.18	4.14	0.89	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	11.86	18.64	0.00	0.00	0.00	0.00	1.69	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	12.84	16.15	0.41	0.41	0.41	0.00	0.83	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	13.12	6.90	0.92	0.00	0.00	0.00	0.23	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	0.00	10.54	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	12.30	8.84	0.00	0.77	0.00	0.00	0.38	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	7.50	10.76	0.98	0.00	0.33	0.33	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	8.69	17.39	0.00	0.67	1.34	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	11.56	10.40	0.39	0.00	0.00	0.00	0.00	0.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	37.66	26.70	1.71	0.68	0.34	0.00	0.68	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	2.48	14.91	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	9.91	4.72	2.83	0.94	1.42	0.00	0.47	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	7.24	8.45	1.21	0.60	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	16.79	18.31	0.51	0.00	1.53	0.00	0.00	0.51
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	12.36	13.96	0.40	0.00	0.40	0.40	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	9.87	15.79	0.49	0.00	0.99	0.49	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	17.71	10.62	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	12.25	12.25	0.58	0.00	0.58	0.00	0.00	0.58
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	8.34	8.34	0.44	0.00	0.44	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	18.65	10.17	1.70	0.00	2.54	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	8.95	9.55	0.60	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	16.01	15.04	0.97	0.00	2.43	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	43.37	2.28	1.14	2.28	0.00	0.00	0.00	0.00
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	24.12	2.08	2.91	0.42	0.00	0.00	0.42	0.00
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	82.09	11.24	3.37	0.00	0.00	1.12	0.00	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	222.65	56.77	3.17	0.95	0.32	0.00	0.32	1.27
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	83.97	36.34	0.42	0.84	0.42	0.42	0.42	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	154.45	117.20	0.93	1.39	0.70	1.39	2.90	1.39
Hep-2 cells mock treated, biol_rep2	11899-125E9	174.88	135.38	0.68	2.53	1.52	0.84	2.70	0.68
Hep-2 cells mock treated, biol_rep3	11900-125F1	174.04	111.93	2.28	1.37	1.59	0.91	2.05	1.14
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	170.19	137.40	1.20	2.40	1.53	1.97	2.73	1.31
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	185.25	152.16	1.93	3.22	1.50	1.72	1.93	0.43
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	175.45	120.56	1.29	2.15	1.29	1.94	3.44	1.51
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	84.81	37.86	1.49	1.62	1.25	0.50	1.25	0.12
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	77.54	39.28	1.54	0.34	1.20	0.51	0.51	0.17
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	90.02	41.97	1.28	0.96	1.92	0.32	0.96	0.64
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	87.30	27.98	7.83	1.68	0.00	0.00	0.00	2.80
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	206.01	51.07	4.76	1.30	0.00	1.73	1.30	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	171.85	34.37	7.93	5.29	2.64	2.64	2.64	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	117.10	88.18	10.58	0.71	0.35	0.35	1.41	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	105.34	50.13	4.36	0.00	1.45	0.00	0.73	0.73
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	93.19	45.63	3.15	1.05	0.70	0.17	0.17	0.52
Hepatocyte, donor1	11523-119I2	39.95	0.00	0.00	0.00	0.00	0.00	1.21	0.00
Hepatocyte, donor2	11603-120I1	78.65	5.39	0.00	2.15	0.00	0.00	1.08	1.08
Hepatocyte, donor3	11684-122I1	347.26	53.99	1.84	0.00	1.23	0.61	0.61	3.68
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	432.73	145.55	0.65	2.61	1.96	0.65	3.92	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	50.69	27.62	0.52	0.52	1.40	0.35	0.52	0.17
Iris Pigment Epithelial Cells, donor1	11530-119I9	84.11	57.08	4.53	1.23	0.14	0.69	0.14	0.27
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	327.94	54.13	0.00	0.00	6.37	3.18	3.18	3.18
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	353.79	46.73	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	785.42	162.50	0.00	0.00	54.17	27.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	323.94	58.14	0.00	1.38	12.46	1.38	2.77	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	372.90	77.58	0.00	2.50	5.01	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	617.15	59.34	11.87	0.00	11.87	23.74	11.87	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	379.31	76.89	0.00	2.56	12.81	7.69	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	379.37	41.14	4.57	0.00	13.71	4.57	0.00	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	332.99	86.09	1.62	1.62	14.62	9.75	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	255.10	61.69	1.67	0.00	6.67	1.67	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	290.45	50.83	0.00	0.00	3.63	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	308.37	74.11	1.32	1.32	7.94	6.62	1.32	1.32
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	251.66	55.43	2.22	1.11	4.43	3.33	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	377.16	41.91	0.00	5.24	0.00	10.48	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	202.19	36.53	0.63	0.00	9.45	4.41	0.63	2.52
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	230.45	34.03	1.55	0.00	7.73	3.09	0.00	1.55
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	204.89	29.27	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	235.80	54.27	0.65	1.29	8.40	1.94	0.65	1.29
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	367.06	46.69	0.00	0.00	8.05	1.61	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	203.12	23.90	0.00	0.00	23.90	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	291.73	44.00	0.00	2.44	9.78	3.26	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	285.05	56.67	2.10	0.84	4.20	1.68	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	201.21	14.37	0.00	0.00	0.00	14.37	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	366.48	42.60	1.61	0.00	8.84	4.02	0.80	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	286.22	56.32	0.92	0.92	3.69	1.85	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	165.89	45.24	0.00	0.00	30.16	15.08	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	272.84	33.04	0.47	1.89	3.30	0.94	0.94	1.42
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	351.91	61.67	2.72	0.91	1.81	1.81	0.91	0.91
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	221.14	14.74	0.00	0.00	14.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	463.81	79.63	2.15	3.23	6.46	3.23	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	509.46	97.83	2.54	1.27	10.16	2.54	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	262.89	49.29	0.00	0.00	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	448.29	68.87	2.55	1.91	5.10	3.19	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	548.62	118.47	1.82	1.82	3.65	1.82	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	410.91	47.41	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	452.00	74.26	1.43	2.86	5.71	2.14	0.71	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	560.80	92.91	3.32	3.32	6.64	6.64	0.00	3.32
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	500.37	229.33	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	393.85	79.02	2.47	2.16	8.33	4.01	0.93	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	653.24	158.04	3.51	1.76	7.02	5.27	1.76	1.76
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	606.62	169.73	6.29	3.14	12.57	6.29	0.00	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	545.18	124.47	0.00	1.39	15.30	3.48	1.39	0.70
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	717.04	123.93	0.00	2.21	13.28	0.00	2.21	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	710.00	139.41	0.00	0.00	3.24	6.48	0.00	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	641.74	85.45	3.49	0.87	4.36	0.87	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	942.66	98.99	0.00	4.50	11.25	4.50	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	763.12	132.41	6.97	3.48	6.97	3.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	663.53	89.61	0.00	1.07	6.40	3.20	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	759.22	185.65	0.00	0.00	5.54	1.39	0.00	4.16
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	621.21	179.52	2.85	2.85	11.40	8.55	0.00	2.85
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	683.88	119.66	0.92	1.84	14.73	4.60	0.92	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	680.70	75.63	3.03	3.03	6.05	6.05	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	875.42	130.38	6.21	0.00	6.21	6.21	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	715.84	96.22	2.11	2.11	7.40	7.40	1.06	2.11
Keratinocyte - epidermal, donor1	11272-116H3	182.05	261.53	5.14	2.86	14.04	6.69	2.77	1.47
Keratinocyte - epidermal, donor2	11349-117G8	291.06	223.71	4.10	1.76	4.10	6.44	0.59	1.17
Keratinocyte - epidermal, donor3	11421-118F8	228.12	149.94	2.27	1.51	2.27	2.46	1.51	1.33
Keratinocyte - oral, donor1	11251-116E9	398.56	400.83	5.68	2.61	20.09	4.20	3.52	2.61
Keratocytes, donor1	11527-119I6	289.16	91.12	5.16	1.72	0.69	0.34	1.38	0.69
Keratocytes, donor2	11607-120I5	118.35	125.38	1.17	1.17	1.17	1.17	0.00	0.00
Keratocytes, donor3	11688-122I5	135.95	66.20	4.15	0.99	0.20	1.38	0.79	1.38
Krukenberg tumor cell line:HSKTC	10687-109F3	109.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Lens Epithelial Cells, donor1	11529-119I8	130.53	48.54	2.16	2.16	2.16	1.08	3.24	0.00
Lens Epithelial Cells, donor2	11609-120I7	19.84	7.50	1.85	0.35	0.00	0.00	0.12	0.00
Lens Epithelial Cells, donor3	11690-122I7	126.44	55.60	9.59	1.11	0.50	0.40	0.10	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	109.21	36.52	6.05	0.83	0.12	0.95	0.47	0.59
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	106.33	38.23	3.07	0.56	0.28	0.00	0.56	1.40
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	81.85	21.57	4.56	1.42	0.16	0.16	0.31	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	105.39	26.89	2.69	1.61	0.00	0.54	0.54	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	117.56	38.14	2.52	0.63	0.32	0.32	0.63	0.32
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	80.32	20.81	3.67	0.97	0.43	0.22	0.32	0.22
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	116.96	31.60	4.10	2.05	0.82	0.00	0.00	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	134.75	41.97	4.55	1.52	0.51	0.25	0.00	0.25
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	79.38	20.27	5.49	1.55	0.42	0.42	0.70	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	155.84	37.58	3.56	1.58	0.40	0.79	0.00	0.79
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	147.16	36.45	3.88	1.16	0.39	0.78	0.78	0.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	77.39	16.11	3.15	0.37	0.37	0.19	0.00	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	119.86	31.36	1.74	1.74	0.35	0.70	0.35	0.70
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	151.22	43.17	3.82	0.95	0.24	0.95	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	83.51	18.27	4.40	0.69	0.14	0.00	0.27	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	146.59	54.82	5.24	3.39	0.62	0.00	1.54	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	118.46	41.77	1.87	0.31	0.00	0.31	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	94.24	26.90	5.31	0.73	0.18	0.55	0.18	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	104.00	31.27	2.96	1.65	0.00	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	123.01	37.49	2.05	0.59	0.88	0.88	1.17	0.59
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	68.70	25.14	4.48	0.50	0.25	0.00	0.75	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	128.52	43.65	6.30	0.97	0.00	0.00	0.00	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	143.80	46.32	3.23	0.27	0.00	0.27	0.81	0.54
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	66.45	22.40	3.63	0.76	0.30	0.45	0.61	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	123.38	27.48	4.67	0.52	0.52	0.52	1.56	1.04
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	135.69	51.30	3.77	1.05	0.42	0.63	0.42	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	65.86	16.24	3.01	0.45	0.30	0.00	0.60	0.30
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	127.94	38.52	8.25	2.75	1.38	0.00	0.69	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	111.76	35.75	4.14	1.32	0.00	0.00	0.56	1.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	66.90	20.04	2.97	1.17	0.74	0.21	0.32	0.21
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	96.43	62.51	2.91	0.97	0.48	0.00	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	132.65	36.39	4.30	0.99	0.33	0.66	0.33	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	69.63	18.71	6.32	0.37	0.37	0.25	0.74	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	102.18	31.10	5.18	0.37	0.37	1.11	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	119.34	38.79	3.95	1.73	0.49	0.00	0.74	0.00
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	72.73	24.75	3.99	0.69	0.27	0.41	0.14	0.55
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	114.82	41.49	6.43	0.96	0.64	0.32	0.64	0.00
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	120.51	39.26	3.96	0.91	0.00	0.00	0.61	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	77.12	26.03	5.04	0.42	0.84	0.42	0.56	0.28
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	111.65	42.31	4.27	0.36	0.71	0.71	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	135.74	50.42	2.42	0.00	0.48	0.97	0.97	0.48
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	75.00	21.47	4.82	1.24	0.62	0.31	0.16	0.16
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	103.13	42.61	3.58	0.72	0.00	0.00	0.36	0.36
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	167.58	57.17	3.27	0.33	0.98	0.33	0.98	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	72.98	20.72	3.06	0.71	0.24	0.47	0.24	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	108.04	36.75	8.29	0.99	0.12	0.37	0.87	0.37
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	139.85	46.36	4.35	0.51	0.77	0.26	0.51	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	62.65	23.57	3.58	0.90	0.00	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	131.43	6.80	2.27	2.27	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	92.06	15.34	3.07	0.77	0.77	0.00	0.77	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	108.37	10.39	3.71	0.74	0.74	0.00	0.74	0.74
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	252.18	30.04	5.92	3.39	1.69	0.42	1.27	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	187.08	27.43	3.52	0.70	0.00	0.70	1.41	0.70
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	207.34	24.28	4.67	2.80	1.87	0.00	0.93	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	213.32	21.13	5.15	2.06	0.52	1.03	2.06	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	228.38	20.22	5.95	2.38	2.38	2.38	1.19	3.57
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	153.58	29.63	7.69	1.81	0.68	0.68	0.68	0.45
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	226.55	25.30	5.82	4.94	0.87	0.29	1.74	3.49
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	282.26	25.21	7.65	2.25	0.90	0.45	0.45	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	294.82	37.12	9.62	2.03	0.95	0.68	0.81	1.22
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	299.38	33.38	3.08	2.57	1.03	1.03	4.62	2.57
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	259.70	28.93	8.82	2.47	0.35	1.06	1.06	0.00
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	278.52	29.98	8.66	4.00	0.00	1.33	0.67	0.67
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	222.09	25.47	7.13	2.55	1.02	1.53	3.06	2.04
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	154.48	25.08	6.14	2.13	0.00	0.53	1.33	0.80
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	153.42	19.08	5.29	2.46	0.19	0.57	0.76	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	161.98	20.86	3.68	1.84	1.84	1.23	3.68	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	159.01	33.43	4.89	3.26	1.63	0.82	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	101.41	13.12	3.75	1.87	0.21	0.83	0.62	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	84.36	13.45	0.84	1.40	0.00	0.00	0.84	1.12
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	139.10	24.73	2.06	1.03	2.06	0.00	0.00	2.06
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	109.73	11.61	3.48	1.74	0.58	0.58	0.87	0.87
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	84.00	9.27	3.29	0.00	0.60	0.00	0.30	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	73.58	9.96	1.66	0.55	0.55	0.00	1.11	0.00
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	149.17	18.73	2.83	1.41	1.06	1.41	2.12	1.77
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	98.46	12.54	1.84	0.37	0.37	1.11	0.74	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	88.65	10.36	3.45	1.15	0.00	1.15	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	117.81	14.97	4.22	0.77	0.00	0.00	1.54	1.54
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	69.07	9.06	2.26	1.70	1.13	0.57	0.57	1.70
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	72.20	9.85	0.82	0.00	0.82	0.82	0.00	1.64
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	84.95	11.30	4.07	0.90	0.90	0.00	0.00	0.90
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	73.25	8.62	0.72	1.44	1.44	0.72	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	88.13	9.71	2.24	0.00	4.48	2.24	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	72.46	11.52	1.11	0.00	0.37	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	80.98	6.89	1.29	1.29	0.43	0.00	0.43	1.29
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	85.63	3.43	0.86	0.86	0.00	0.00	0.86	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	91.29	11.99	1.33	1.33	0.67	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	99.55	12.67	1.21	3.02	1.21	1.21	1.81	1.21
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	91.01	10.66	3.55	2.13	0.71	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	103.80	20.28	4.12	2.75	0.00	0.34	1.03	0.69
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	99.84	13.42	2.15	1.07	1.07	0.00	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	117.16	11.45	4.04	0.67	2.02	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	126.31	15.56	4.07	2.22	0.37	1.11	1.11	1.11
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	126.76	16.28	1.16	1.16	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	130.10	23.27	5.29	1.06	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	131.25	21.61	2.00	3.20	1.20	0.80	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	327.09	37.07	5.81	3.63	1.45	0.73	0.73	0.73
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	320.40	27.59	13.80	3.83	4.60	2.30	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	279.20	32.06	7.40	4.44	1.97	2.96	1.97	1.97
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	317.09	30.11	5.65	2.82	3.76	2.82	0.00	1.88
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	322.81	29.16	10.56	0.50	1.01	1.01	0.50	1.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	260.46	32.90	7.21	2.70	2.70	0.45	1.80	1.80
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	411.34	25.82	5.16	3.44	0.00	3.44	1.72	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	440.44	42.31	11.58	2.23	2.67	0.00	2.67	4.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	435.99	42.23	10.56	4.69	0.78	2.74	3.52	5.08
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	424.21	37.60	9.90	5.28	0.66	1.98	3.96	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	554.73	47.22	16.09	4.67	0.52	0.52	2.59	4.15
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	524.20	60.38	11.81	8.31	0.44	0.44	3.50	3.50
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	358.38	41.37	9.50	3.91	1.68	1.12	0.56	4.47
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	491.11	57.41	13.25	3.09	0.00	0.44	2.21	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	351.00	49.37	10.41	2.31	2.31	1.16	1.54	1.54
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	331.16	48.61	8.61	4.56	1.01	1.01	4.56	4.56
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	367.67	50.95	8.65	2.40	0.00	0.00	1.44	1.44
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	312.07	46.12	10.73	3.18	2.39	0.40	3.58	1.99
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	301.38	41.93	7.29	3.65	3.04	0.00	5.47	1.82
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	314.03	51.88	6.92	2.08	0.00	0.00	1.38	2.08
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	305.51	48.64	6.08	3.80	0.76	1.52	0.38	2.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	284.55	42.35	2.58	4.13	1.55	1.03	4.65	1.55
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	259.40	48.98	4.23	0.60	1.21	1.21	0.60	0.60
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	238.94	27.25	5.07	2.22	1.27	0.63	1.58	1.58
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	221.23	27.19	4.80	1.60	0.53	0.53	0.00	0.53
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	217.80	31.03	1.72	1.72	0.00	1.15	1.72	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	221.12	39.08	6.69	3.60	1.54	0.51	0.51	2.57
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	149.96	17.68	2.83	1.41	0.00	0.00	2.12	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	137.90	24.97	2.84	1.13	0.00	0.00	1.13	1.13
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	147.27	25.79	4.16	2.08	0.83	0.00	0.83	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	108.84	12.53	1.57	0.78	0.78	1.57	3.92	3.13
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	138.21	20.46	0.84	0.42	0.84	0.84	0.00	0.84
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	122.66	17.66	0.46	2.32	0.00	0.46	0.00	0.93
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	132.47	22.08	0.67	2.68	1.34	0.00	1.34	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	144.89	24.06	1.07	1.07	0.00	0.00	0.53	0.53
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	130.93	17.38	2.83	2.83	1.62	0.81	1.21	1.21
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	138.58	12.85	0.92	1.84	0.00	0.00	0.00	0.92
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	179.60	16.00	2.67	0.89	0.89	0.89	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	174.38	23.93	4.56	1.14	0.57	2.28	1.14	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	169.48	16.87	1.53	2.30	0.00	0.77	0.00	0.77
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	159.78	17.51	2.19	1.64	1.09	0.00	1.09	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	153.68	15.15	2.23	1.78	1.34	0.45	0.89	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	166.63	20.02	5.46	1.04	0.00	0.52	0.52	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	188.32	32.49	2.65	1.99	0.00	0.66	1.33	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	322.18	27.02	2.08	2.08	0.00	0.00	4.16	2.08
Macrophage - monocyte derived, donor1	11232-116C8	10.48	0.23	1.60	0.23	0.00	0.00	0.23	0.00
Macrophage - monocyte derived, donor2	11313-117C8	18.35	1.65	0.92	0.37	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor3	11389-118C3	42.34	4.06	3.54	0.52	0.00	0.00	0.00	0.13
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	77.53	47.26	1.59	0.00	1.06	1.59	0.00	0.00
Mallassez-derived cells, donor2	11929-125I3	87.78	24.88	3.64	1.43	0.79	1.58	0.95	0.48
Mallassez-derived cells, donor3	11930-125I4	155.80	119.53	2.78	1.25	6.39	5.28	0.69	0.97
Mammary Epithelial Cell, donor1	11273-116H4	455.87	170.59	3.69	1.40	1.69	1.20	1.40	0.40
Mammary Epithelial Cell, donor2	11350-117G9	429.98	184.44	3.19	3.19	1.45	1.74	1.45	0.58
Mammary Epithelial Cell, donor3	11422-118F9	198.79	132.20	2.00	2.00	1.00	1.50	0.50	0.50
Mast cell - stimulated, donor1	11487-119E2	225.07	71.86	4.75	2.03	0.68	0.00	0.68	0.68
Mast cell, donor1	11563-120D6	16.00	2.49	0.54	0.43	0.00	0.22	0.00	0.00
Mast cell, donor2	11565-120D8	103.12	5.35	2.08	1.78	0.00	0.89	0.00	1.78
Mast cell, donor3	11566-120D9	81.95	1.35	1.35	1.13	0.23	0.23	0.00	1.13
Mast cell, donor4	11567-120E1	80.13	4.96	1.06	0.53	0.53	0.35	0.18	1.24
Mast cell, expanded and stimulated, donor5	11940-126A5	98.03	17.08	1.00	2.11	0.33	1.33	0.11	1.00
Mast cell, expanded and stimulated, donor8	11942-126A7	114.99	38.52	2.92	1.17	0.58	2.92	0.58	3.50
Mast cell, expanded, donor5	11939-126A4	13.08	1.03	0.34	0.11	0.00	0.11	0.00	0.23
Mast cell, expanded, donor8	11941-126A6	43.18	10.21	0.67	0.84	0.17	0.33	0.33	0.50
Melanocyte - dark, donor1	11502-119F8	70.05	32.54	7.46	0.30	0.30	0.20	0.20	0.10
Melanocyte - dark, donor2	11582-120F7	84.10	30.11	5.88	0.00	0.35	0.00	0.35	1.73
Melanocyte - dark, donor3	11663-122F7	158.86	88.09	5.07	0.36	0.36	0.51	0.72	0.29
Melanocyte - light, donor1	11274-116H5	145.27	138.69	10.58	1.88	0.94	2.82	1.88	1.41
Melanocyte - light, donor2	11351-117H1	163.11	175.39	8.19	3.41	2.05	1.36	0.68	0.00
Melanocyte - light, donor3	11423-118G1	111.87	84.99	6.94	0.87	0.00	0.87	0.87	1.73
Melanocyte, donor1 (MC+1)	12641-134G4	145.57	151.29	3.54	1.46	0.94	1.25	1.98	1.04
Melanocyte, donor2 (MC+2)	12739-135I3	105.16	121.02	5.65	1.88	0.00	0.81	0.54	1.08
Melanocyte, donor3 (MC+3)	12837-137B2	255.27	240.53	9.11	4.02	1.34	2.41	1.07	1.61
Meningeal Cells, donor1	11493-119E8	212.14	54.21	7.32	0.62	0.87	1.24	0.12	0.00
Meningeal Cells, donor2	11573-120E7	131.60	35.21	8.36	0.88	0.44	0.00	1.32	0.00
Meningeal Cells, donor3	11654-122E7	155.42	47.68	5.54	1.39	0.33	0.49	0.57	0.33
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	60.45	21.10	0.29	0.29	0.29	0.00	0.00	0.00
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	43.57	12.38	1.51	0.60	0.20	0.70	0.30	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	187.93	107.76	1.31	0.00	2.63	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	159.60	83.72	2.62	2.62	1.31	1.31	0.00	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	174.38	98.31	2.87	1.44	2.87	0.72	2.15	1.44
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	24.35	4.87	1.91	0.42	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	33.17	5.03	3.02	1.01	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	114.93	31.20	3.08	0.22	0.22	0.44	0.44	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	116.89	35.80	1.46	0.00	0.00	0.00	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	99.64	29.46	2.86	0.61	0.20	0.41	0.41	0.41
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	178.12	49.03	3.88	0.83	0.14	0.69	1.11	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	134.56	44.98	6.69	0.74	0.74	0.74	0.00	0.37
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	150.52	85.65	6.05	1.32	0.79	0.66	0.66	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	98.22	22.55	4.75	0.30	0.00	0.59	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	91.09	4.67	0.00	4.67	0.00	2.34	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	94.14	36.50	3.20	0.64	0.64	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	159.50	86.84	1.42	0.35	1.06	2.13	1.42	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	116.96	48.78	6.25	0.63	0.00	0.00	0.63	0.63
Mesenchymal stem cells - umbilical, donor0	11214-116A8	152.40	37.01	0.73	1.45	0.73	0.00	0.00	0.73
Mesothelial Cells, donor1	11247-116E5	30.76	5.30	3.98	0.00	0.00	0.00	0.27	0.27
Mesothelial Cells, donor2	12156-128G5	35.03	9.51	4.00	0.50	0.00	0.00	0.50	0.00
Mesothelial Cells, donor3	11402-118D7	50.80	10.48	6.72	0.72	0.00	0.14	0.14	0.22
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	18.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	17.98	0.74	0.74	1.72	0.00	0.00	0.49	0.25
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	18.85	3.83	2.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	17.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	12.40	0.31	1.86	1.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	27.17	2.70	1.66	0.21	0.00	0.00	0.00	0.21
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	13.90	0.00	2.32	2.32	0.00	0.00	2.32	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	50.80	1.50	3.25	2.00	0.25	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	59.58	6.05	1.86	0.47	0.00	0.00	0.47	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	52.23	1.02	3.25	0.81	0.00	0.00	0.20	0.41
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	60.98	2.77	2.77	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	102.62	25.65	0.00	8.55	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	72.56	1.77	1.77	0.88	0.00	0.00	0.88	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	73.71	6.84	3.42	0.76	0.00	0.00	0.76	0.38
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	167.12	6.58	3.95	1.32	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	127.55	8.91	4.03	1.06	0.42	0.00	0.42	0.85
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	55.25	4.60	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	141.58	8.35	6.26	0.60	0.00	0.00	0.60	0.30
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	45.27	5.03	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	67.90	33.95	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	115.16	11.29	4.77	1.76	0.00	0.00	0.75	0.25
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	46.82	6.65	1.43	0.71	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	75.74	3.32	1.66	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	103.15	8.52	4.14	1.38	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	45.22	5.89	2.73	0.63	0.00	0.00	0.21	0.21
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	97.84	12.03	3.67	1.02	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	73.16	6.65	3.65	0.86	0.00	0.00	0.21	0.00
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	36.68	3.56	0.89	0.22	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	92.43	7.67	2.63	0.22	0.44	0.00	0.22	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	27.38	4.06	1.01	0.51	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	54.68	6.63	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	77.73	5.16	2.99	0.54	0.00	0.00	0.54	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	24.11	2.06	0.59	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	25.08	2.18	1.09	3.27	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	24.51	1.92	0.48	0.00	0.00	0.00	0.48	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	14.01	2.40	0.80	0.00	0.00	0.00	0.40	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	21.94	4.11	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	22.53	1.50	0.50	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	26.95	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	18.35	4.08	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	14.45	1.75	0.88	0.44	0.00	0.00	0.00	0.44
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	15.45	1.10	1.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	14.73	0.00	0.00	0.00	0.00	0.00	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	21.07	1.49	0.74	0.74	0.00	0.00	0.00	0.25
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	23.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	11.05	8.84	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	20.85	1.37	3.08	0.34	0.00	0.00	0.00	0.34
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	24.07	1.75	1.31	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	9.23	1.07	0.71	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	12.62	0.84	0.56	0.00	0.28	0.00	0.28	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	17.46	1.66	0.42	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	4.08	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	9.35	0.60	0.30	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	15.86	1.67	1.25	0.83	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	7.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	4.62	0.92	0.00	0.92	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	7.40	2.28	0.00	0.57	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	3.73	0.69	0.83	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	3.11	0.26	0.00	0.26	0.00	0.00	0.26	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	6.86	0.86	0.43	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	5.08	0.64	0.64	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	4.00	0.53	0.53	0.00	0.00	0.00	0.00	0.27
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	12.27	1.80	1.80	0.60	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	5.37	0.28	0.28	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	5.10	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	4.64	0.00	0.66	0.00	0.00	0.00	0.00	0.22
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	3.41	0.76	0.76	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	3.69	0.85	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	4.67	0.74	0.25	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	2.61	0.00	0.00	0.65	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	3.53	0.59	0.00	0.59	0.00	0.00	0.00	0.29
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	6.34	0.86	0.86	0.29	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	9.48	0.41	2.06	0.82	0.00	0.00	0.41	0.00
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	5.06	0.60	0.89	0.30	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	7.53	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	7.13	0.00	1.78	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	13.80	0.33	0.99	1.97	0.00	0.00	0.33	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	32.61	0.00	2.10	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	13.24	0.40	1.78	1.58	0.00	0.00	0.20	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	36.32	0.93	2.79	0.93	0.00	0.00	0.00	0.93
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	18.03	0.75	1.50	2.63	0.00	0.38	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	18.91	0.80	2.93	1.60	0.00	0.00	0.27	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	16.85	0.68	1.70	1.36	0.00	0.00	0.11	0.11
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	11.79	0.74	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	13.56	0.00	1.10	0.73	0.00	0.00	0.00	0.37
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	34.22	1.56	0.00	0.00	0.00	0.00	1.56	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	6.41	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	7.73	3.86	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	9.09	0.00	1.01	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	8.01	0.00	0.42	0.42	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	25.88	1.36	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	8.90	0.64	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	13.59	1.51	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	268.38	5.71	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	97.87	26.10	3.26	6.52	3.26	0.00	0.00	3.26
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	52.28	9.50	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	175.69	12.55	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	65.92	25.85	4.09	0.65	0.22	0.22	0.22	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	53.83	19.86	2.09	1.05	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	48.06	10.01	0.00	0.00	2.00	0.00	0.67	1.33
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	33.81	5.01	3.34	1.67	0.42	0.00	0.42	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	52.86	6.27	3.04	0.00	0.19	0.38	0.57	0.19
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	89.37	19.15	6.38	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	21.76	4.08	2.04	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	22.05	9.19	1.84	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	32.65	4.60	1.67	1.26	0.00	0.00	0.42	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	36.49	2.56	2.56	0.46	0.23	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	28.10	6.49	2.43	0.81	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	60.13	9.04	2.10	0.42	0.00	0.00	0.21	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	33.40	22.27	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	50.13	10.42	4.96	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	34.38	2.98	2.98	0.27	0.00	0.00	0.81	0.54
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	43.75	4.31	3.63	0.68	0.91	0.00	0.00	0.23
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	23.35	4.90	1.80	0.33	0.33	0.16	0.16	0.16
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	43.01	10.39	1.28	0.55	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	63.12	16.97	3.71	1.06	0.00	0.53	0.53	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	69.04	13.81	6.60	2.40	0.00	0.00	0.00	0.60
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	24.61	2.63	0.33	0.00	0.33	0.00	1.31	0.33
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	40.01	3.74	3.74	0.81	0.16	0.16	0.16	0.16
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	57.32	9.35	0.71	0.35	0.18	0.00	0.18	0.18
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	52.74	10.55	4.22	0.70	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	45.97	5.52	2.30	1.38	0.00	0.46	0.92	0.00
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	24.74	5.46	1.93	0.32	0.00	0.00	0.00	0.32
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	32.42	7.24	2.41	1.03	0.00	0.34	1.72	2.41
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	10.11	12.64	7.59	0.00	0.00	0.00	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	53.69	11.14	1.56	0.22	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	48.27	7.62	0.85	0.42	0.00	0.00	0.42	0.42
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	53.40	5.70	1.19	0.00	0.24	0.24	0.24	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	16.74	3.43	2.58	1.29	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	27.08	9.03	0.00	0.00	0.00	9.03	0.00	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	38.32	7.00	2.67	0.33	0.00	0.00	0.00	0.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	35.17	7.21	0.45	0.45	0.00	0.45	0.45	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	30.95	7.94	1.59	1.19	0.00	0.00	0.40	0.00
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	32.50	4.64	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	19.68	1.89	1.89	0.38	0.00	0.38	0.00	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	28.03	10.10	2.61	0.33	0.00	0.00	0.00	0.33
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	32.25	6.54	2.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	37.09	3.62	0.90	0.00	0.45	0.00	0.00	0.00
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	36.16	7.06	2.65	0.88	0.00	0.88	0.88	0.88
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	60.50	13.96	0.66	1.33	0.66	0.66	0.00	0.66
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	20.34	1.98	1.49	0.00	0.00	0.00	0.50	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	37.52	6.89	0.77	0.00	0.38	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	24.20	5.14	2.42	0.30	0.91	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	55.70	8.40	1.11	0.44	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	24.40	4.74	2.71	0.68	0.00	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	10.22	20.44	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	9.75	2.44	0.61	0.00	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	18.25	1.26	1.26	0.00	0.00	0.00	0.00	0.31
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	17.86	3.93	1.51	0.00	0.00	0.00	0.00	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	20.57	3.16	2.37	0.00	0.00	0.79	0.00	0.79
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	31.74	6.80	1.13	0.00	0.00	0.00	5.67	1.13
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	25.29	20.23	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	68.82	33.29	1.74	0.37	0.25	0.75	0.75	0.37
Myoblast, donor2	11322-117D8	113.92	81.89	2.88	1.73	1.53	0.77	1.15	0.77
Myoblast, donor3	11398-118D3	77.02	29.93	2.52	0.67	0.17	0.34	0.67	0.00
NK T cell leukemia cell line:KHYG-1	10777-110G3	635.98	50.93	3.65	2.77	4.96	1.02	1.46	1.90
Natural Killer Cells, donor1	11230-116C6	59.66	9.23	1.54	0.62	3.38	0.31	0.31	0.31
Natural Killer Cells, donor2	11311-117C6	57.60	2.41	0.30	1.51	5.43	0.90	0.30	0.30
Natural Killer Cells, donor3	11387-118C1	48.96	5.71	1.10	0.74	2.21	0.55	0.37	0.37
Neural stem cells, donor1	11275-116H6	45.73	14.52	2.90	1.09	1.09	0.36	0.73	0.73
Neural stem cells, donor2	11352-117H2	55.84	9.63	3.85	0.00	0.00	1.93	0.00	0.00
Neurons, donor1	11494-119E9	62.58	21.62	2.28	0.00	0.00	1.14	1.14	0.00
Neurons, donor2	11574-120E8	35.23	11.45	1.54	0.44	0.22	1.32	0.22	0.22
Neurons, donor3	11655-122E8	37.82	16.44	2.47	0.82	0.82	0.00	0.82	0.00
Neutrophils, donor1	11233-116C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	3.67	1.22	0.61	0.00	0.00	0.00	0.00	0.00
Nucleus Pulposus Cell, donor1	11252-116F1	118.74	45.48	3.80	1.66	0.00	0.00	0.83	0.24
Nucleus Pulposus Cell, donor2	11409-118E5	76.19	26.37	0.98	0.65	0.65	0.00	0.33	0.00
Nucleus Pulposus Cell, donor3	11462-119B4	76.01	39.51	4.21	0.80	0.40	0.00	0.40	0.20
Olfactory epithelial cells, donor1	11933-125I7	51.21	12.53	3.30	0.69	0.00	0.14	0.55	0.00
Olfactory epithelial cells, donor2	11934-125I8	49.50	11.00	2.46	1.30	0.00	0.29	0.72	0.87
Olfactory epithelial cells, donor3	11935-125I9	59.70	13.96	3.97	0.68	0.11	0.00	0.23	0.34
Olfactory epithelial cells, donor4	11936-126A1	114.05	39.64	4.38	0.78	0.10	0.19	0.78	0.39
Oligodendrocyte - precursors, donor1	11496-119F2	116.75	65.60	8.43	0.60	0.60	0.60	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	50.41	18.29	1.70	0.21	0.00	0.21	0.21	0.64
Osteoblast - differentiated, donor2	11353-117H3	32.01	6.86	0.00	0.00	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	73.86	37.24	3.72	0.00	0.00	3.72	0.62	0.62
Osteoblast, donor1	11277-116H8	103.97	28.34	4.30	0.98	0.39	0.59	0.20	0.20
Osteoblast, donor2	11354-117H4	115.18	28.09	3.51	0.00	0.70	0.00	0.70	0.00
Osteoblast, donor3	11426-118G4	132.76	38.75	4.98	1.42	0.36	0.53	0.53	0.36
Pancreatic stromal cells, donor1	11249-116E7	39.84	14.40	2.02	0.17	0.17	0.08	0.34	0.08
Pericytes, donor1	11491-119E6	59.53	16.91	4.01	1.22	0.22	0.11	0.45	0.11
Pericytes, donor2	11571-120E5	43.46	14.49	2.26	0.91	0.23	0.00	0.23	0.68
Pericytes, donor3	11652-122E5	169.27	87.69	6.51	1.83	0.81	0.81	1.02	0.61
Perineurial Cells, donor1	11499-119F5	108.84	58.21	7.23	1.13	0.11	0.57	0.57	0.23
Perineurial Cells, donor2	11579-120F4	82.63	36.62	6.07	0.37	0.83	0.09	0.55	0.46
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	55.78	23.59	1.91	1.27	0.64	0.32	0.32	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	42.12	11.02	0.98	1.22	1.47	0.49	0.49	0.73
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	50.21	11.52	1.55	0.91	0.65	0.39	0.13	0.39
Placental Epithelial Cells, donor1	11278-116H9	33.96	6.22	0.00	0.24	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor2	11355-117H5	52.12	17.74	4.44	0.00	0.00	0.00	0.00	1.11
Placental Epithelial Cells, donor3	11427-118G5	52.03	19.63	1.57	0.00	0.59	0.39	0.59	0.00
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	30.06	8.54	3.48	1.58	0.00	0.00	0.32	0.00
Preadipocyte - breast, donor1	11467-119B9	43.15	9.19	3.00	0.38	0.19	0.19	0.38	0.00
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	66.70	10.70	2.87	1.04	0.26	0.13	0.13	0.13
Preadipocyte - breast, donor2	11328-117E5	43.45	9.23	3.38	0.68	0.00	0.45	0.45	0.45
Preadipocyte - omental, donor1	11468-119C1	48.48	15.24	2.77	0.85	0.21	0.21	0.64	0.43
Preadipocyte - omental, donor2	11329-117E6	24.44	4.36	2.18	0.44	0.00	0.00	0.00	0.00
Preadipocyte - omental, donor3	11403-118D8	67.76	16.19	3.87	0.72	0.29	0.00	0.72	0.29
Preadipocyte - perirenal, donor1	11469-119C2	49.21	26.58	1.97	0.00	0.00	0.00	0.00	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	112.10	43.30	4.91	0.31	1.23	2.46	0.61	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	183.45	57.20	3.19	1.42	1.06	1.42	1.24	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	124.48	42.40	1.70	0.51	0.34	1.02	0.17	0.85
Preadipocyte - visceral, donor1	11280-116I2	154.53	64.09	3.82	0.75	0.56	1.02	0.09	0.75
Preadipocyte - visceral, donor2	11357-117H7	68.11	18.87	0.92	1.84	0.00	0.46	0.92	2.30
Preadipocyte - visceral, donor3	11429-118G7	123.09	38.77	2.93	1.46	0.73	0.63	0.52	0.84
Prostate Epithelial Cells (polarized), donor1	11253-116F2	81.61	52.65	0.60	2.72	1.66	1.21	0.30	0.75
Prostate Epithelial Cells, donor2	11331-117E8	92.62	49.43	3.66	2.03	1.08	0.27	1.08	2.44
Prostate Epithelial Cells, donor3	11404-118D9	199.45	104.53	1.84	2.88	0.80	0.49	1.53	1.90
Prostate Stromal Cells, donor1	11254-116F3	60.48	20.73	2.62	1.25	0.23	0.00	0.23	0.46
Prostate Stromal Cells, donor2	11332-117E9	91.98	17.39	4.12	0.90	0.18	0.18	0.36	1.26
Prostate Stromal Cells, donor3	11405-118E1	26.49	6.88	1.67	0.94	0.00	0.21	0.63	0.31
Renal Cortical Epithelial Cells, donor1	11516-119H4	203.66	97.82	11.31	1.46	0.36	0.36	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	127.26	37.71	5.20	0.90	0.21	0.42	0.62	0.42
Renal Epithelial Cells, donor1	11517-119H5	241.44	101.95	9.13	0.00	0.00	0.00	0.00	0.00
Renal Epithelial Cells, donor2	11597-120H4	174.98	40.55	7.11	2.13	0.00	0.00	0.00	1.42
Renal Epithelial Cells, donor3	11678-122H4	148.10	50.18	7.52	1.16	0.42	0.64	0.85	0.21
Renal Glomerular Endothelial Cells, donor1	11514-119H2	85.79	30.64	3.40	2.72	0.68	0.00	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	103.77	50.54	5.39	0.67	0.54	0.54	0.27	1.21
Renal Glomerular Endothelial Cells, donor3	11675-122H1	128.10	27.31	3.11	1.11	0.00	0.22	0.44	0.44
Renal Glomerular Endothelial Cells, donor4	11783-124B1	187.65	32.61	9.98	2.00	0.00	0.00	0.00	0.67
Renal Mesangial Cells, donor1	11518-119H6	110.26	42.70	5.94	1.54	0.22	0.44	0.66	0.00
Renal Mesangial Cells, donor2	11598-120H5	145.46	50.16	10.03	1.88	0.63	0.63	0.00	1.25
Renal Mesangial Cells, donor3	11679-122H5	96.82	40.22	9.43	1.11	0.55	0.28	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	229.77	66.57	2.95	0.27	0.54	0.27	0.27	0.27
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	161.09	30.36	2.53	1.27	0.42	0.00	0.00	0.42
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	151.38	45.51	5.79	1.74	0.19	0.00	0.58	0.39
Retinal Pigment Epithelial Cells, donor0	11215-116A9	79.08	24.89	4.41	0.26	0.78	0.78	0.00	0.00
Retinal Pigment Epithelial Cells, donor1	11528-119I7	153.49	84.14	7.67	1.71	1.71	0.85	0.57	1.14
Retinal Pigment Epithelial Cells, donor2	11608-120I6	161.57	49.40	2.06	1.03	3.09	1.03	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	180.15	90.33	5.77	4.27	1.00	1.00	1.51	0.75
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	70.43	14.17	2.41	0.27	0.00	0.00	0.27	0.94
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	325.20	19.65	0.89	1.79	0.89	0.89	0.89	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	331.32	18.71	2.20	2.75	0.55	0.00	1.65	3.30
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	341.65	27.26	2.90	0.58	0.58	0.58	0.00	1.16
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	199.20	19.11	3.51	1.04	0.65	0.39	1.17	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	213.11	24.43	6.45	2.09	0.79	0.30	1.19	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	201.77	27.77	6.25	1.56	1.00	0.56	0.33	0.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	221.29	25.68	5.58	1.61	0.37	0.00	1.36	0.25
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	257.33	28.32	6.41	3.03	1.17	0.35	1.52	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	231.36	30.51	6.24	2.77	0.92	0.92	1.85	2.08
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	326.66	25.05	4.93	3.01	0.82	0.41	0.68	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	239.01	23.60	4.54	3.03	1.21	0.61	1.36	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	229.01	24.73	4.30	0.18	0.18	0.72	0.54	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	336.69	25.10	7.32	2.15	0.72	0.86	1.58	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	287.60	23.50	6.44	2.58	0.75	0.64	1.07	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	263.31	24.78	7.08	1.99	0.89	0.89	0.66	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	347.18	25.81	3.06	1.91	0.00	0.57	0.96	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	240.45	21.15	5.31	2.33	0.28	0.75	0.19	0.84
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	337.11	44.16	8.83	1.50	0.19	0.56	0.75	1.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	263.02	25.08	5.31	1.86	0.53	0.53	1.19	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	279.27	19.95	8.27	2.63	0.88	0.49	1.07	0.88
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	278.23	34.75	8.21	1.34	0.76	0.57	0.38	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	235.91	25.31	7.48	0.64	0.21	0.53	0.32	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	251.15	18.78	5.61	2.52	1.68	0.00	1.12	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	250.37	31.79	5.13	1.54	1.20	0.00	1.20	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	223.72	20.60	4.74	1.46	0.55	0.36	0.91	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	232.27	20.23	7.73	1.72	0.25	0.61	0.86	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	257.09	37.48	7.12	2.69	0.27	0.54	0.54	1.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	289.42	32.79	4.95	0.94	0.47	0.47	0.71	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	227.18	21.43	5.75	2.18	0.40	0.00	0.79	0.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	228.47	30.40	6.78	3.04	0.47	0.94	0.94	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	243.02	26.54	6.22	2.07	0.21	0.62	0.62	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	188.69	15.93	4.20	2.21	0.22	0.22	1.33	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	197.19	32.79	4.60	1.67	0.63	0.42	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	203.09	21.40	3.23	0.81	0.54	0.27	0.40	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	146.62	13.96	5.11	1.02	0.34	0.17	0.51	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	178.14	24.48	6.17	1.54	0.39	0.58	1.35	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	240.88	17.37	3.78	1.55	0.17	0.17	0.86	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	126.06	11.11	3.70	1.65	0.55	0.14	0.27	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	146.77	13.79	4.27	1.15	0.49	0.82	0.49	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	221.73	23.01	3.75	1.36	0.51	0.17	0.68	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	216.31	17.16	7.10	1.48	0.44	0.44	0.74	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	202.31	19.72	4.80	1.87	0.80	0.27	0.53	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	378.85	51.99	4.70	1.24	0.41	0.41	0.28	0.55
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	228.34	33.57	6.67	1.90	0.95	0.71	1.19	1.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	269.46	34.06	7.86	2.42	1.21	0.20	0.40	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	311.53	47.37	5.74	2.35	0.75	0.66	1.04	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	333.64	51.71	6.64	2.45	0.35	0.00	1.75	1.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	292.84	44.12	4.84	2.12	0.30	0.30	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	262.64	21.66	4.16	2.08	0.24	0.49	1.35	1.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	225.46	27.80	5.68	1.75	0.15	0.58	0.29	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	257.36	35.29	1.83	1.83	0.00	1.22	1.83	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	251.07	25.32	4.22	2.71	0.60	0.00	0.90	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	297.21	30.31	4.75	2.49	1.13	0.68	1.36	1.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	285.16	22.77	4.19	1.80	0.00	0.60	1.80	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	338.99	33.06	4.37	4.25	0.94	0.24	3.42	4.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	273.85	21.34	3.42	5.55	0.21	0.21	2.13	8.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	271.04	21.03	1.80	6.01	0.60	0.00	0.00	1.80
Schwann Cells, donor1	11498-119F4	97.23	26.52	4.33	0.38	0.38	0.00	0.19	0.38
Schwann Cells, donor2	11578-120F3	180.33	6.80	3.40	0.00	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	104.06	16.87	6.13	0.44	0.22	0.44	0.66	0.22
Sebocyte, donor1	11220-116B5	269.50	331.95	2.19	2.19	18.62	4.38	0.00	1.64
Sebocyte, donor2	11301-117B5	181.98	198.53	5.06	6.89	8.27	4.60	2.76	2.30
Sebocyte, donor3	11378-118B1	152.52	173.75	4.12	2.06	4.33	1.44	2.06	1.86
Sertoli Cells, donor1	11255-116F4	110.99	24.85	9.94	0.00	0.00	1.66	0.00	0.00
Sertoli Cells, donor2	11333-117F1	129.92	56.49	8.47	8.47	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	137.86	74.17	4.40	1.06	0.26	0.44	0.70	1.32
Skeletal Muscle Cells, donor2	11358-117H8	46.98	28.91	3.61	1.45	0.00	1.45	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	163.86	45.15	2.51	0.00	0.00	0.84	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	150.18	170.76	1.89	1.57	1.41	0.94	1.41	1.26
Skeletal Muscle Cells, donor5	11455-119A6	155.78	193.39	3.57	2.38	3.12	1.78	1.78	1.64
Skeletal Muscle Cells, donor6	11459-119B1	174.37	107.42	2.15	1.23	4.00	2.15	0.62	1.08
Skeletal Muscle Satellite Cells, donor1	11240-116D7	106.73	136.84	3.02	0.63	1.01	0.76	0.88	0.63
Skeletal Muscle Satellite Cells, donor2	11321-117D7	70.35	80.33	2.57	1.00	0.57	1.14	0.00	1.43
Skeletal Muscle Satellite Cells, donor3	11397-118D2	139.49	135.22	2.68	1.88	1.69	1.98	0.40	1.39
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	98.24	41.54	4.38	0.84	0.08	0.25	0.76	0.17
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	180.22	41.25	7.24	0.72	0.00	0.72	0.00	0.00
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	57.52	16.24	1.79	0.69	0.28	0.00	0.41	0.41
Skin - palm, donor1	10286-104F7	915.96	32.23	5.37	0.00	0.00	0.00	0.00	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	148.05	121.96	1.87	2.59	4.04	1.87	1.30	3.03
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	507.91	215.11	3.27	4.91	15.54	10.63	2.45	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	207.33	93.48	1.56	2.86	2.73	1.95	0.65	1.43
Small Airway Epithelial Cells, donor1	11256-116F5	139.01	72.56	1.95	1.67	1.81	1.25	1.11	1.67
Small Airway Epithelial Cells, donor2	11334-117F2	147.41	48.81	2.11	0.98	0.56	0.70	1.13	0.98
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	427.97	227.52	3.38	0.85	10.78	4.02	2.54	0.85
Small Airway Epithelial Cells, donor3	11406-118E2	150.73	32.75	1.05	1.35	0.37	0.37	0.67	0.67
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	149.97	37.03	4.94	0.00	0.00	1.54	1.23	0.93
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	212.55	31.13	5.34	2.45	2.00	2.00	0.67	0.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	89.94	25.86	4.11	1.18	0.00	0.59	0.59	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	256.13	64.09	6.85	2.21	1.33	0.88	0.00	0.66
Smooth Muscle Cells - Aortic, donor2	11360-117I1	107.11	36.23	4.33	0.00	0.39	0.79	0.39	0.39
Smooth Muscle Cells - Aortic, donor3	11432-118H1	93.48	26.27	6.18	0.00	0.77	0.00	0.00	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	63.05	30.02	1.00	0.00	0.00	0.00	2.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	95.95	37.00	5.99	1.46	0.67	1.86	0.13	0.40
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	105.29	32.14	6.43	1.33	0.44	0.44	1.77	0.89
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	76.31	31.62	2.18	0.38	0.38	0.64	0.26	0.38
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	49.16	10.74	2.60	0.65	0.00	0.00	0.33	0.33
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	67.04	24.81	5.02	0.30	0.30	0.00	0.59	0.00
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	49.40	23.06	6.83	1.28	0.28	0.14	0.28	0.00
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	189.03	124.45	4.88	0.98	0.49	0.98	0.49	0.49
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	141.87	64.54	3.04	1.83	0.00	0.61	0.91	0.00
Smooth Muscle Cells - Carotid, donor1	11285-116I7	105.57	60.11	5.30	0.25	0.76	1.01	0.00	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	134.66	61.21	12.24	0.00	0.00	0.00	6.12	12.24
Smooth Muscle Cells - Carotid, donor3	11434-118H3	119.21	57.70	4.29	0.48	0.48	1.91	0.00	0.95
Smooth Muscle Cells - Colonic, donor1	11239-116D6	51.32	15.34	1.33	0.44	0.59	0.00	0.44	0.74
Smooth Muscle Cells - Colonic, donor2	11320-117D6	63.28	16.36	3.44	0.86	0.00	0.43	0.22	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	76.41	24.56	2.52	0.52	0.21	0.21	0.21	0.21
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	113.53	37.74	7.42	0.93	0.46	0.77	0.31	0.62
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	106.71	60.36	5.39	2.16	2.16	1.08	2.16	1.08
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	65.15	24.51	3.89	0.90	0.30	0.30	0.30	0.30
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	160.46	71.01	4.44	0.00	0.34	1.02	0.34	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	84.89	67.06	3.77	0.24	0.08	0.47	0.24	0.39
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	133.75	30.90	2.52	2.82	0.10	0.20	0.70	2.62
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	86.01	33.68	7.74	1.14	1.14	1.14	0.46	0.23
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	95.40	22.94	3.02	0.60	0.60	0.60	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	138.03	43.71	3.97	0.79	0.53	0.26	0.79	0.00
Smooth Muscle Cells - Prostate, donor1	11257-116F6	29.83	6.92	1.33	0.40	0.00	0.13	0.13	0.13
Smooth Muscle Cells - Prostate, donor2	11335-117F3	59.73	13.77	3.01	1.00	0.13	0.25	0.00	0.63
Smooth Muscle Cells - Prostate, donor3	11465-119B7	27.90	4.06	2.03	0.00	0.25	0.00	0.00	0.25
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	76.89	32.87	4.52	0.90	0.45	0.90	0.15	0.30
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	60.76	18.75	3.75	1.50	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	1075.12	24.55	1.29	6.46	0.00	0.00	0.00	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	123.71	54.41	1.86	1.40	0.47	0.93	0.00	0.47
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	110.57	27.26	3.03	2.02	1.51	2.52	0.50	0.50
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	76.78	19.74	7.21	1.25	0.31	0.63	0.94	0.63
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	118.29	77.58	5.01	1.47	0.59	0.29	0.29	0.29
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	150.79	58.48	3.33	0.33	0.33	0.58	0.33	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	172.85	73.34	4.20	1.87	0.47	0.47	0.93	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	85.78	21.01	4.03	1.01	0.29	0.29	0.43	0.72
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	102.49	28.56	4.84	1.78	0.25	1.53	0.76	0.25
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	84.99	23.69	4.89	0.56	0.75	0.19	0.19	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	140.16	23.90	4.61	0.98	0.28	0.84	0.14	0.42
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	104.48	36.78	7.62	0.84	0.17	0.50	0.25	0.42
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	161.43	77.62	1.90	0.95	0.95	4.29	0.48	1.90
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	78.54	20.31	4.89	0.73	0.24	0.49	0.00	0.49
Smooth Muscle Cells - Uterine, donor1	11258-116F7	69.38	26.96	4.20	0.88	0.66	0.88	0.44	0.88
Smooth Muscle Cells - Uterine, donor3	11466-119B8	52.37	7.02	1.76	0.59	0.59	0.00	0.29	0.00
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	45.29	3.50	1.36	1.17	0.00	0.00	0.19	0.39
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	65.58	7.93	2.38	0.79	0.26	0.53	0.79	0.53
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	40.91	0.74	2.23	1.12	0.00	0.00	0.74	0.74
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	58.21	12.22	2.52	1.44	0.00	0.36	0.72	0.36
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	58.77	5.39	0.28	0.57	0.00	0.00	0.00	0.28
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	115.80	11.03	3.15	1.18	0.39	0.39	0.79	0.79
Smooth muscle cells - airway, control, donor1	11966-126D4	111.99	11.43	1.27	2.03	0.25	0.25	2.54	1.27
Smooth muscle cells - airway, control, donor2	11967-126D5	85.85	11.58	2.80	0.00	0.00	0.00	0.00	1.20
Smooth muscle cells - airway, control, donor3	11968-126D6	75.66	8.78	1.67	0.84	0.00	0.00	0.84	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	116.88	15.13	2.75	1.38	0.00	0.00	0.46	0.46
Synoviocyte, donor1	11291-117A4	143.07	39.56	2.02	1.18	0.84	0.84	0.67	0.34
Synoviocyte, donor2	11368-117I9	105.60	10.90	3.35	0.84	0.34	0.00	0.34	0.50
Synoviocyte, donor3	11440-118H9	41.55	7.82	1.34	0.00	0.00	0.22	0.45	0.22
Trabecular Meshwork Cells, donor1	11532-120A2	174.73	86.83	2.50	2.14	1.43	1.07	0.36	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	269.56	166.49	3.96	0.00	3.96	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	159.54	64.14	6.48	0.46	0.00	0.23	0.93	0.69
Tracheal Epithelial Cells, donor1	11292-117A5	250.18	114.69	0.86	0.79	2.44	1.86	0.65	0.65
Tracheal Epithelial Cells, donor2	11369-118A1	223.82	183.23	3.48	1.16	4.64	5.41	0.77	0.39
Tracheal Epithelial Cells, donor3	11441-118I1	280.60	194.71	1.72	1.15	5.15	4.58	0.57	1.15
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	73.45	15.50	2.95	1.35	0.00	0.00	0.12	0.86
Urethra, donor2	10319-105A4	66.54	12.59	3.60	0.00	0.00	1.80	0.00	0.00
Urothelial Cells, donor1	11520-119H8	210.14	136.55	2.39	2.39	1.33	3.19	1.06	0.53
Urothelial Cells, donor2	11600-120H7	185.06	117.77	1.60	1.60	2.40	2.00	0.80	1.20
Urothelial Cells, donor3	11681-122H7	174.20	92.83	1.38	1.15	1.83	0.23	1.60	0.69
Urothelial cells, donor0	11216-116B1	153.57	78.24	2.67	0.67	1.11	0.89	0.89	0.67
Whole blood (ribopure), donor090309, donation1	12179-129A1	118.34	44.49	5.34	1.78	0.89	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	105.79	40.03	4.29	4.29	1.43	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	84.88	26.70	2.05	2.05	1.37	0.68	0.00	1.37
Whole blood (ribopure), donor090325, donation1	12176-128I7	89.53	33.40	2.41	1.72	1.03	0.34	0.34	0.00
Whole blood (ribopure), donor090325, donation2	12177-128I8	93.55	34.86	0.00	1.74	1.16	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	107.25	42.69	1.04	2.08	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	89.94	38.55	3.67	1.84	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	73.94	36.52	2.74	4.56	0.00	0.00	0.91	0.91
Wilms' tumor cell line:G-401	10809-111A8	90.79	63.41	5.55	1.23	0.62	0.37	0.37	0.25
Wilms' tumor cell line:HFWT	10597-108E3	93.28	158.41	4.40	4.40	0.00	0.00	2.64	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	646.90	87.43	5.59	4.75	3.63	3.07	1.96	0.84
achilles tendon, donor2	10292-104G4	146.72	4.13	0.00	2.07	0.00	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	254.96	130.79	4.59	1.78	1.27	0.76	2.04	2.29
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	295.09	520.54	6.50	2.09	13.00	3.25	1.86	0.70
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	529.32	431.03	9.50	2.97	4.15	1.66	2.85	1.54
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	227.76	143.68	0.00	0.27	4.35	3.27	1.63	0.00
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	663.64	520.85	4.22	4.50	17.99	7.87	6.46	5.06
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	124.99	31.72	1.48	0.21	0.85	0.42	0.00	0.00
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	145.09	65.33	0.82	0.54	10.07	8.44	1.63	0.54
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	544.63	409.79	6.61	3.97	1.76	0.88	2.64	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	396.93	277.28	4.49	3.68	2.86	1.63	3.27	3.68
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	458.97	173.96	1.55	3.11	1.94	1.55	1.94	1.16
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	2930.02	415.29	14.72	16.56	75.44	30.73	7.91	8.65
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	503.17	300.34	7.80	7.80	7.80	0.00	7.80	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	353.45	103.64	0.70	3.49	2.32	2.09	3.02	0.46
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	972.43	321.81	2.33	8.03	10.87	3.37	6.47	2.85
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	792.27	343.09	1.75	6.72	8.48	7.31	2.63	2.34
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	323.47	56.70	0.46	0.46	0.46	0.00	0.46	0.46
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	384.93	81.84	0.41	2.88	1.65	1.23	4.11	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	197.37	20.87	3.07	0.31	1.23	2.46	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	238.96	31.58	5.12	0.85	0.00	1.28	0.00	0.85
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	229.90	38.82	6.07	1.52	0.61	0.91	0.91	0.91
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	220.25	39.48	3.37	0.48	0.72	1.20	0.48	0.24
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	511.85	77.51	1.34	2.45	2.45	0.89	2.67	1.34
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	437.61	48.36	1.00	0.33	0.67	0.00	0.33	1.67
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	323.33	423.67	1.86	0.00	5.57	0.00	3.72	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	304.34	408.30	4.90	4.90	3.77	7.91	3.01	3.39
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	804.23	355.88	13.08	4.36	0.87	2.18	3.05	2.62
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	569.84	144.33	3.75	0.00	1.87	1.87	1.87	0.00
adenocarcinoma cell line:IM95m	10796-110I4	259.29	27.55	1.65	0.00	0.94	1.18	0.24	0.71
adipose tissue, adult, pool1	10010-101C1	271.46	44.67	5.74	2.48	0.31	0.31	0.31	2.95
adipose, donor1	10184-103D4	3.52	1.17	0.00	0.00	0.00	0.00	0.00	0.59
adipose, donor2	10185-103D5	6.49	2.43	0.00	0.00	0.00	0.00	0.00	0.00
adipose, donor3	10186-103D6	32.95	7.08	0.82	0.27	0.27	0.27	0.00	0.54
adipose, donor4	10187-103D7	188.09	12.13	0.87	0.00	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	87.59	22.73	2.53	0.16	0.79	0.47	0.63	0.32
adrenal gland, adult, pool1	10081-102A9	69.12	10.91	3.64	3.64	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	85.78	8.27	1.07	0.27	0.53	0.53	0.27	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	243.32	100.04	15.36	2.86	2.50	2.86	2.86	1.43
amniotic membrane cells, donor1	12235-129G3	31.30	8.11	1.16	0.46	0.00	0.23	0.23	0.00
amniotic membrane cells, donor2	12236-129G4	49.36	5.07	2.03	0.68	0.00	0.00	0.00	0.34
amniotic membrane cells, donor3	12237-129G5	69.53	15.61	0.29	0.29	0.59	0.00	0.29	0.00
amygdala - adult, donor10196	10167-103B5	49.80	8.30	0.00	0.00	0.00	0.00	0.00	0.00
amygdala, adult, donor10252	10151-102I7	21.49	2.03	0.81	0.20	0.20	0.20	0.20	0.00
amygdala, newborn, donor10223	10360-105E9	49.38	8.39	1.94	1.94	2.26	2.26	0.32	0.00
anaplastic carcinoma cell line:8305C	10428-106D5	126.44	54.24	1.66	1.40	0.89	0.76	0.64	0.89
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	258.35	29.78	1.99	0.66	1.76	3.97	0.88	0.22
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	80.50	20.04	0.00	0.33	0.00	0.33	0.00	0.67
aorta, adult, pool1	10052-101G7	87.48	14.71	2.75	0.39	0.59	0.00	0.78	0.00
appendix, adult	10189-103D9	277.50	36.09	4.66	3.49	0.39	0.39	0.39	3.88
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	596.04	192.95	4.82	3.10	4.47	13.76	1.03	1.72
artery, adult	10190-103E1	62.50	8.15	1.36	0.00	0.00	0.00	1.36	0.00
astrocytoma cell line:TM-31	10425-106D2	263.66	39.98	10.72	2.17	0.00	0.14	1.30	1.45
b cell line:RPMI1788	10427-106D4	226.47	149.15	2.68	0.15	3.72	10.26	0.59	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	86.84	18.31	3.33	1.66	0.28	0.00	0.00	0.00
bile duct carcinoma cell line:HuCCT1	10432-106D9	225.85	84.45	2.78	0.79	0.50	0.60	0.79	1.09
bile duct carcinoma cell line:TFK-1	10496-107C1	204.70	32.30	4.18	2.01	0.33	3.18	3.35	0.67
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	423.34	114.64	5.03	2.80	0.56	1.12	2.24	1.12
bladder, adult, pool1	10011-101C2	123.09	16.19	3.26	1.30	0.33	0.22	0.33	0.87
blood, adult, pool1	10053-101G8	6.64	4.43	2.21	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	65.08	8.56	0.86	0.00	0.00	0.00	0.00	0.00
bone marrow, adult	10192-103E3	255.76	99.20	2.02	4.05	0.67	0.00	1.35	4.05
brain, adult, donor1	10084-102B3	5.13	0.00	1.03	0.00	0.00	0.00	0.00	0.00
brain, adult, pool1	10012-101C3	12.47	1.78	0.56	0.11	0.00	0.33	0.11	0.00
brain, fetal, pool1	10085-102B4	45.41	18.70	5.34	2.67	0.00	0.00	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	533.87	44.27	10.57	3.96	0.00	0.66	4.29	0.99
breast carcinoma cell line:MDA-MB-453	10419-106C5	107.47	6.49	1.37	0.50	0.75	1.37	0.00	0.00
breast, adult, donor1	10080-102A8	115.54	19.57	5.05	1.26	0.00	0.00	0.00	2.53
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	299.81	118.53	3.94	2.92	1.65	1.40	1.14	1.78
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	419.61	10.51	7.42	1.86	0.62	0.93	1.55	0.93
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	332.67	35.45	2.30	2.07	3.45	3.68	2.53	1.38
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	155.90	27.60	8.96	0.73	0.24	0.24	0.97	0.73
carcinoid cell line:NCI-H1770	10703-109H1	1.41	0.00	0.00	0.00	0.00	0.47	0.00	0.00
carcinoid cell line:NCI-H727	10735-110B6	181.24	32.16	0.88	0.66	0.00	1.75	0.22	0.11
carcinoid cell line:SK-PN-DW	10719-109I8	739.95	73.84	9.19	14.89	15.21	27.25	17.43	14.26
carcinosarcoma cell line:JHUCS-1	10642-109A3	125.90	36.47	1.86	1.33	1.06	0.80	0.53	1.06
caudate nucleus - adult, donor10196	10177-103C6	70.23	6.91	1.15	0.00	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10252	10164-103B2	10.04	1.51	0.33	0.17	0.00	0.00	0.00	0.00
caudate nucleus, adult, donor10258	10379-105H1	3.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
caudate nucleus, newborn, donor10223	10354-105E3	57.50	11.72	0.37	1.46	1.10	3.66	0.00	1.10
cerebellum - adult, donor10196	10173-103C2	34.96	5.83	0.00	0.00	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	10.68	1.71	0.43	0.00	0.00	0.00	0.21	0.21
cerebellum, adult, pool1	10083-102B2	5.86	0.69	0.34	0.69	0.00	0.00	0.00	0.00
cerebellum, newborn, donor10223	10357-105E6	35.70	2.49	0.83	0.83	0.00	0.00	0.83	0.00
cerebral meninges, adult	10188-103D8	28.74	1.51	1.26	0.25	0.00	0.00	0.00	0.76
cerebrospinal fluid, donor2	10294-104G6	59.93	7.31	0.00	0.73	0.00	0.00	0.00	0.00
cervical cancer cell line:D98-AH2	10552-107I3	251.48	319.92	1.73	2.30	1.15	2.44	6.47	1.01
cervical cancer cell line:ME-180	10553-107I4	620.11	45.57	5.63	0.99	1.82	0.83	1.82	0.83
cervix, adult, pool1	10013-101C4	136.59	16.06	3.04	1.05	0.10	0.10	0.42	1.68
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	96.28	15.47	3.07	1.25	0.70	0.98	0.84	1.25
chondrosarcoma cell line:SW 1353	10700-109G7	181.57	13.06	0.00	0.00	0.00	0.00	0.00	0.00
choriocarcinoma cell line:BeWo	10423-106C9	54.93	9.20	1.37	0.12	0.00	0.25	0.12	0.50
choriocarcinoma cell line:SCH	10785-110H2	98.32	56.80	10.47	0.25	0.25	0.25	0.62	0.37
choriocarcinoma cell line:T3M-3	10618-108G6	15.18	0.47	0.47	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	72.37	15.67	1.71	0.00	0.28	0.28	1.14	0.28
chorionic membrane cells, donor2	12239-129G7	17.70	3.88	1.79	0.40	0.00	0.10	0.30	0.30
chorionic membrane cells, donor3	12240-129G8	97.81	15.39	0.55	0.55	0.00	0.00	0.55	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	360.50	106.03	17.17	9.09	1.01	1.01	5.05	4.04
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	401.68	221.11	4.03	2.31	6.15	5.57	1.73	1.92
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	587.94	205.48	4.01	1.69	1.90	1.69	2.53	1.27
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	470.46	85.77	0.51	1.28	2.05	3.08	2.82	0.77
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	423.29	94.82	2.90	1.94	2.90	1.69	1.94	0.00
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	458.94	95.29	1.02	2.44	4.68	1.63	1.02	1.02
chronic myelogenous leukemia cell line:K562	10454-106G4	361.89	148.99	2.36	0.59	4.42	2.06	1.77	1.47
chronic myelogenous leukemia cell line:KU812	10409-106B4	989.07	792.82	6.26	4.17	26.32	9.64	2.61	3.39
clear cell carcinoma cell line:JHOC-5	10638-108I8	249.84	18.74	1.83	2.51	1.14	0.69	2.29	2.29
clear cell carcinoma cell line:TEN	10636-108I6	136.03	12.84	2.95	2.60	1.04	0.87	1.04	1.39
colon carcinoma cell line:CACO-2	10513-107D9	93.17	49.42	1.46	0.18	0.55	0.73	0.18	0.00
colon carcinoma cell line:COLO-320	10420-106C6	2449.24	975.67	74.12	22.04	26.61	205.24	21.66	11.02
colon, adult, donor1	10082-102B1	77.35	15.47	2.38	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	115.27	22.56	3.41	0.82	0.12	0.12	0.59	2.12
colon, fetal, donor1	10070-101I7	97.64	29.66	1.85	1.85	0.00	0.00	0.00	2.47
common myeloid progenitor CMP, donor1	12130-128D6	330.01	362.10	0.00	9.17	0.00	0.00	4.58	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	100.15	0.00	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	193.34	103.68	0.42	0.42	1.27	1.70	0.85	0.00
cord blood derived cell line:COBL-a 24h infection	10453-106G3	138.56	79.69	0.30	1.81	0.30	2.11	1.66	1.51
cord blood derived cell line:COBL-a untreated	10449-106F8	130.72	62.19	0.71	0.42	1.13	2.68	0.71	0.85
corpus callosum, adult, pool1	10042-101F6	26.76	3.10	1.44	0.55	0.00	0.00	0.11	0.11
cruciate ligament, donor2	10295-104G7	158.85	14.59	1.62	0.81	0.00	0.81	1.62	0.00
diaphragm, fetal, donor1	10069-101I6	75.44	20.87	3.21	0.00	0.00	0.00	0.80	0.80
diencephalon, adult	10193-103E4	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	233.51	225.48	2.07	5.74	5.74	1.15	2.98	1.84
ductal cell carcinoma cell line:KLM-1	10438-106E6	399.28	45.90	2.82	1.54	1.03	1.54	1.28	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	143.23	155.02	11.31	1.93	0.96	2.65	2.17	0.72
ductus deferens, adult	10196-103E7	58.31	6.98	0.50	0.50	0.00	1.00	0.00	1.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	46.09	12.96	2.88	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	95.63	29.43	1.47	2.94	0.00	1.47	0.00	0.74
dura mater, adult, donor1	10041-101F5	57.65	4.05	2.40	1.16	0.08	0.08	0.25	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	46.19	5.55	0.22	0.00	0.22	0.00	0.00	0.00
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	30.52	10.46	0.72	0.00	0.14	0.14	0.14	0.00
embryonic pancreas cell line:1B2C6	10604-108F1	248.50	25.90	6.17	1.85	0.00	0.62	0.00	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	252.46	50.25	11.20	3.63	1.51	2.12	1.51	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	354.44	46.31	4.94	1.85	1.54	0.62	1.54	0.31
embryonic pancreas cell line:2C6	10603-108E9	450.52	36.78	7.88	1.31	0.00	1.31	1.31	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	116.98	87.82	11.06	2.35	0.67	1.34	1.34	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	162.57	47.30	4.17	0.36	0.18	0.54	1.63	0.18
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	74.62	23.80	0.16	1.13	0.64	0.16	0.00	0.48
epidermoid carcinoma cell line:A431	10426-106D3	355.71	132.83	4.89	1.67	1.78	2.89	1.22	0.78
epidermoid carcinoma cell line:Ca Ski	10431-106D8	471.62	112.41	6.82	1.76	3.74	3.30	0.77	0.66
epididymis, adult	10197-103E8	74.93	5.44	2.09	1.47	0.00	0.00	0.42	1.67
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	57.66	49.50	3.55	1.24	0.53	0.71	1.06	0.35
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	148.25	90.05	10.62	1.57	0.39	3.15	3.15	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	264.46	406.91	1.70	4.32	11.14	4.59	4.19	2.23
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	491.31	667.29	2.17	8.96	10.24	9.05	4.72	3.94
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	257.00	398.49	1.57	4.37	10.87	4.15	2.80	1.68
esophagus, adult, pool1	10015-101C6	189.21	35.14	4.78	1.49	0.32	0.21	0.85	2.12
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	93.43	115.59	6.26	1.88	0.25	1.25	0.63	0.50
eye - muscle inferior rectus, donor1	10272-104E2	137.63	12.07	0.00	0.00	0.00	0.00	0.00	2.41
eye - muscle lateral, donor2	10298-104H1	44.19	2.10	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle medial, donor2	10299-104H2	10.42	1.49	0.00	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	57.32	12.61	3.44	1.15	0.00	0.00	1.15	0.00
eye - vitreous humor, donor1	10268-104D7	74.33	5.83	0.00	4.37	0.00	0.00	0.00	0.00
eye, fetal, donor1	10054-101G9	77.54	20.34	2.03	0.76	0.00	0.00	0.51	0.25
fibrosarcoma cell line:HT-1080	10758-110E2	65.39	12.57	1.92	0.13	0.38	0.00	0.13	0.00
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	43.21	2.14	0.95	0.24	0.00	0.00	0.47	0.24
frontal lobe, adult, pool1	10040-101F4	3.47	0.38	0.38	0.09	0.00	0.00	0.00	0.09
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	29.72	3.60	1.20	0.00	0.00	0.00	0.00	0.00
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	114.11	19.20	1.92	0.55	1.01	2.74	0.27	0.46
gall bladder, adult	10198-103E9	153.07	15.21	4.35	1.69	0.00	0.48	1.21	2.66
gamma delta positive T cells, donor1	11937-126A2	146.02	30.60	4.83	1.07	0.54	0.00	0.54	1.07
gamma delta positive T cells, donor2	11938-126A3	17.18	3.73	0.00	0.75	0.75	1.12	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	17.11	5.70	0.42	0.00	0.21	0.21	0.00	0.21
gastric adenocarcinoma cell line:MKN45	10612-108F9	51.84	7.16	0.77	0.39	0.58	1.16	0.00	0.00
gastric cancer cell line:AZ521	10549-107H9	170.19	70.66	4.92	2.62	0.33	0.33	0.49	0.33
gastric cancer cell line:GSS	10560-108A2	440.22	81.46	5.49	0.92	1.83	1.83	0.92	2.75
gastrointestinal carcinoma cell line:ECC12	10615-108G3	348.63	110.57	1.60	3.88	1.37	2.06	1.83	1.60
giant cell carcinoma cell line:LU65	10487-107B1	508.76	53.24	3.67	1.95	4.02	9.87	4.59	1.26
giant cell carcinoma cell line:Lu99B	10433-106E1	192.44	41.71	4.34	1.68	0.98	0.56	0.42	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	249.42	18.46	0.75	1.00	0.00	0.25	0.50	0.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	44.23	5.07	1.16	0.42	0.11	0.32	0.00	0.42
glioblastoma cell line:A172, tech_rep2	10444-106F3	43.11	4.77	1.97	0.14	0.28	0.00	0.14	0.00
glioblastoma cell line:T98G	10485-107A8	162.91	33.33	3.86	0.77	0.22	0.55	0.33	0.44
glioma cell line:GI-1	10413-106B8	192.71	25.48	6.15	1.46	0.00	0.88	1.17	0.29
globus pallidus - adult, donor10196	10175-103C4	61.23	2.92	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, adult, donor10252	10161-103A8	32.95	4.39	0.49	0.24	0.00	0.00	0.24	0.00
globus pallidus, adult, donor10258	10367-105F7	5.48	0.00	0.00	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	60.75	10.13	0.00	0.00	0.53	0.00	0.00	0.00
granulocyte macrophage progenitor, donor1	12131-128D7	332.81	252.06	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	87.43	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	78.40	67.95	5.23	5.23	0.00	5.23	0.00	0.00
granulosa cell tumor cell line:KGN	10624-108H3	149.12	46.08	0.96	0.96	0.00	0.32	0.64	0.00
hIPS +CCl2, biol_rep1	14383-156B9	93.66	13.31	3.21	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	102.88	12.80	1.37	0.91	0.00	0.00	0.46	0.00
hIPS +CCl2, biol_rep3	14385-156C2	74.71	12.24	0.00	1.29	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	149.48	17.25	5.75	0.00	1.44	0.00	1.44	0.00
hIPS, biol_rep2	14381-156B7	117.28	15.77	1.37	0.00	0.00	0.00	0.69	0.00
hIPS, biol_rep3	14382-156B8	18.76	3.31	0.00	1.10	0.00	0.00	0.00	0.00
hairy cell leukemia cell line:Mo	10712-109I1	96.55	20.11	1.15	1.15	1.15	0.57	0.29	0.29
heart - mitral valve, adult	10205-103F7	174.30	44.25	1.79	0.60	0.00	0.00	0.90	0.30
heart - pulmonic valve, adult	10206-103F8	43.14	6.28	0.52	0.00	0.00	0.00	0.52	0.00
heart - tricuspid valve, adult	10207-103F9	206.50	61.62	0.00	0.00	0.83	0.00	0.83	0.83
heart, adult, diseased post-infarction, donor1	10050-101G5	35.30	8.57	1.02	0.61	0.41	0.00	0.20	0.00
heart, adult, diseased, donor1	10051-101G6	41.73	8.09	0.85	0.00	0.00	0.00	1.70	0.43
heart, adult, pool1	10016-101C7	93.14	26.91	0.69	0.46	0.00	0.00	0.23	0.00
heart, fetal, pool1	10046-101G1	80.40	30.09	1.64	0.41	0.10	0.21	0.00	0.10
hepatic mesenchymal tumor cell line:LI90	10778-110G4	78.67	11.72	2.47	0.00	0.31	0.00	0.00	0.00
hepatoblastoma cell line:HuH-6	10633-108I3	347.24	55.89	0.00	0.00	0.00	0.00	0.00	0.00
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	279.22	154.25	2.10	2.21	3.54	2.76	1.55	0.77
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	265.93	148.08	1.34	3.64	3.40	1.82	1.34	0.85
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	284.87	161.99	1.41	3.03	2.43	3.13	1.41	0.91
hepatoma cell line:Li-7	10484-107A7	139.91	32.25	2.45	0.33	2.56	3.34	0.44	0.78
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	220.50	37.99	0.20	0.80	1.31	1.51	0.40	0.20
hippocampus - adult, donor10196	10169-103B7	41.64	5.68	0.95	0.00	0.00	0.00	0.00	0.00
hippocampus, adult, donor10252	10153-102I9	25.10	4.08	1.22	0.61	0.00	0.00	0.00	0.00
hippocampus, adult, donor10258	10374-105G5	8.47	1.00	0.00	0.00	0.50	0.00	0.00	0.00
hippocampus, newborn, donor10223	10363-105F3	46.88	6.34	0.70	1.06	0.35	0.70	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	137.94	19.53	1.83	3.05	0.00	0.00	0.00	1.22
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	89.73	24.35	1.77	0.59	0.79	0.20	0.00	0.59
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	120.09	21.84	1.52	1.78	0.76	0.25	1.02	2.03
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	40.03	9.02	0.56	0.56	0.00	0.00	0.56	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	27.37	7.75	1.29	1.03	0.52	0.00	1.03	0.77
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	36.82	8.73	1.14	0.76	0.76	0.00	0.00	1.52
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	43.79	9.93	0.29	0.00	1.46	0.29	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	29.94	6.25	1.08	1.29	0.43	0.00	0.22	0.22
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	50.88	12.51	0.00	0.00	0.83	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	16.10	6.16	1.42	0.24	0.24	0.00	0.00	0.24
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	23.63	11.73	1.45	0.32	0.80	0.32	0.16	0.16
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	23.57	11.45	0.67	0.00	0.67	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	91.54	28.17	1.88	0.94	0.31	0.16	0.94	0.78
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	97.28	27.02	0.00	0.98	0.00	0.00	3.44	2.95
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	103.86	28.80	1.75	0.00	0.00	0.00	0.87	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	11.84	6.11	1.34	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	10.03	6.98	1.31	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	16.99	5.00	3.00	0.50	0.50	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	5.84	1.88	0.19	0.38	0.00	0.00	0.00	0.19
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	6.37	0.91	1.36	0.00	0.00	0.00	0.00	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	8.46	0.63	0.63	0.31	0.00	0.31	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	17.31	8.00	0.82	0.49	0.33	0.49	0.33	0.49
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	22.35	9.87	1.45	0.29	0.00	0.00	0.29	0.58
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	23.32	10.16	0.90	0.60	0.60	0.00	0.60	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	60.97	20.51	0.37	1.66	0.18	0.18	1.11	1.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	67.90	23.96	1.71	0.86	0.57	0.00	0.29	0.29
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	96.77	22.05	0.41	0.82	0.41	0.00	0.41	0.41
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	8.80	4.58	0.70	0.35	0.00	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	12.35	6.65	0.63	0.63	0.00	0.00	0.00	0.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	14.83	4.54	1.82	0.00	0.00	0.00	0.61	0.30
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	9.31	2.59	0.52	0.00	0.00	0.00	0.52	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	5.31	0.66	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	9.24	3.08	0.00	0.00	0.26	0.00	0.26	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	33.23	12.53	0.77	0.00	1.53	0.26	0.26	0.77
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	14.39	3.79	0.76	0.00	1.51	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	26.88	12.43	2.35	0.34	1.34	1.34	0.34	0.67
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	68.59	19.80	2.17	2.42	0.00	0.00	0.48	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	90.47	21.39	0.89	0.45	0.00	0.00	0.45	1.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	108.78	19.02	2.93	0.49	0.00	0.00	0.49	1.95
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	13.45	3.06	1.22	0.61	0.00	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	13.01	6.51	0.00	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	20.19	4.30	0.99	0.33	0.00	0.00	0.00	0.33
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	14.23	2.74	0.55	0.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	15.56	1.81	0.36	0.00	0.36	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	15.66	2.14	0.36	0.00	0.00	0.00	0.36	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	11.93	5.97	2.39	2.39	2.39	0.00	0.00	1.19
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	26.27	10.29	1.76	0.54	0.68	0.27	0.14	0.41
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	24.25	8.62	0.81	0.54	0.27	0.27	0.00	0.00
immature langerhans cells, donor1	11904-125F5	680.43	91.29	24.94	11.62	1.21	0.97	5.57	1.94
immature langerhans cells, donor2	11905-125F6	224.97	19.01	3.96	0.00	0.00	0.00	0.00	0.00
insula, adult, pool1	10039-101F3	8.23	0.38	0.47	0.66	0.09	0.09	0.00	0.00
keratoacanthoma cell line:HKA-1	10791-110H8	202.89	82.91	7.80	2.93	2.93	0.98	1.63	0.33
kidney, adult, pool1	10017-101C8	52.07	8.51	1.20	0.80	0.00	0.10	0.10	0.50
kidney, fetal, pool1	10045-101F9	56.52	19.59	2.69	0.50	0.00	0.00	0.21	0.14
large cell lung carcinoma cell line:IA-LM	10509-107D5	233.20	158.78	6.67	1.42	0.99	1.85	0.85	0.71
large cell lung carcinoma cell line:NCI-H460	10839-111E2	422.05	99.26	30.69	4.98	1.52	5.39	3.73	2.63
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	294.15	21.29	3.30	1.47	0.18	0.92	0.73	1.10
left atrium, adult, donor1	10079-102A7	33.78	2.72	1.63	1.09	0.00	0.00	0.00	0.00
left ventricle, adult, donor1	10078-102A6	47.53	14.66	0.00	0.51	0.00	0.00	0.00	0.00
leiomyoblastoma cell line:G-402	10721-110A1	223.27	175.38	8.48	1.92	1.92	3.56	1.09	0.00
leiomyoma cell line:10964C	10569-108B2	38.08	7.54	3.95	1.08	0.00	0.00	0.36	0.72
leiomyoma cell line:15242A	10570-108B3	30.98	5.43	2.17	0.54	0.00	0.00	0.00	1.63
leiomyoma cell line:15425	10571-108B4	44.19	4.61	1.46	1.21	0.00	0.24	0.00	0.73
leiomyosarcoma cell line:Hs 5.T	10722-110A2	76.19	12.70	0.00	0.00	0.00	0.00	0.00	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	97.24	12.55	1.05	0.00	0.00	1.05	0.00	1.05
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	671.28	438.82	4.37	4.60	6.26	6.97	2.60	1.77
liposarcoma cell line:KMLS-1	10782-110G8	51.55	11.25	3.44	0.94	0.47	0.47	1.09	0.00
liposarcoma cell line:SW 872	10726-110A6	64.57	9.38	1.71	0.00	0.00	0.24	0.00	0.49
liver, adult, pool1	10018-101C9	133.21	14.10	1.62	0.16	0.00	0.00	0.00	0.97
liver, fetal, pool1	10086-102B5	34.81	26.34	0.00	1.88	0.94	0.94	0.94	0.00
locus coeruleus - adult, donor10196	10182-103D2	54.25	5.98	1.31	0.73	0.00	0.00	0.15	0.00
locus coeruleus, adult, donor10252	10165-103B3	25.84	5.35	0.37	0.18	0.37	0.00	0.00	0.18
locus coeruleus, adult, donor10258	10375-105G6	3.95	0.28	0.28	0.00	0.00	0.00	0.28	0.00
locus coeruleus, newborn, donor10223	10362-105F2	89.17	7.57	2.10	0.00	0.84	2.52	0.42	1.68
lung adenocarcinoma cell line:A549	10499-107C4	96.05	9.96	3.46	0.83	0.28	0.83	0.28	0.14
lung adenocarcinoma cell line:PC-14	10408-106B3	91.69	17.24	2.07	0.00	0.00	0.69	0.00	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	303.18	47.19	4.48	1.45	0.40	0.92	1.19	0.53
lung, adult, pool1	10019-101D1	88.00	13.70	2.72	0.83	0.12	0.12	0.71	1.18
lung, fetal, donor1	10068-101I5	157.54	24.26	0.57	1.43	0.00	0.00	0.29	0.86
lung, right lower lobe, adult, donor1	10075-102A3	30.70	2.29	1.37	0.00	0.00	0.00	0.46	0.46
lymph node, adult, donor1	10077-102A5	133.96	29.82	5.21	0.00	0.47	0.00	1.89	1.89
lymphangiectasia cell line:DS-1	10727-110A7	252.93	275.94	7.23	3.29	7.89	3.07	0.88	1.97
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	325.85	142.17	0.91	2.72	5.28	0.75	1.96	0.91
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	1412.71	151.21	5.95	9.34	11.89	4.25	0.00	1.70
mature adipocyte, donor1	12231-129F8	1487.81	51.06	3.11	5.33	0.00	0.44	0.00	1.78
mature adipocyte, donor2	12232-129F9	862.69	24.28	2.91	2.08	0.83	0.21	1.04	1.25
mature adipocyte, donor3	12233-129G1	1406.73	64.96	5.69	2.13	0.71	0.24	1.19	2.84
mature adipocyte, donor4	12234-129G2	1360.04	53.70	5.00	4.21	0.26	0.00	1.58	3.69
maxillary sinus tumor cell line:HSQ-89	10414-106B9	300.44	130.33	5.48	1.67	1.67	3.10	1.19	0.48
medial frontal gyrus - adult, donor10196	10170-103B8	18.05	3.38	0.00	1.13	0.00	0.00	0.00	0.00
medial frontal gyrus, adult, donor10252	10150-102I6	15.08	1.84	0.55	0.37	0.18	0.00	0.00	0.00
medial frontal gyrus, adult, donor10258	10368-105F8	4.13	0.00	0.32	0.00	0.00	0.00	0.00	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	33.27	8.53	0.00	2.13	0.43	3.41	1.28	0.43
medial temporal gyrus - adult, donor10196	10183-103D3	22.95	1.35	0.17	0.68	0.17	0.17	0.34	0.00
medial temporal gyrus, adult, donor10252	10156-103A3	17.61	1.70	0.85	0.21	0.00	0.21	0.21	0.00
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	13.48	0.00	0.00	1.93	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	53.84	12.92	2.15	1.08	2.51	5.03	1.08	0.00
medulla oblongata - adult, donor10196	10174-103C3	70.09	8.44	1.95	0.00	0.00	0.00	0.00	0.00
medulla oblongata, adult, donor10252	10155-103A2	37.46	8.20	1.08	0.46	0.00	0.00	0.46	0.15
medulla oblongata, adult, pool1	10038-101F2	26.94	4.08	0.57	0.73	0.00	0.00	0.16	0.08
medulla oblongata, newborn, donor10223	10361-105F1	67.35	6.94	0.69	0.69	0.35	0.35	0.35	0.35
medulloblastoma cell line:D283 Med	10838-111E1	918.42	1578.67	23.25	16.83	3.32	5.09	17.49	12.84
medulloblastoma cell line:ONS-76	10759-110E3	128.39	13.69	0.98	0.00	0.12	0.98	0.37	0.12
melanoma cell line:COLO 679	10514-107E1	125.78	44.13	2.59	1.29	0.57	1.29	0.57	0.57
melanoma cell line:G-361	10465-106H6	216.08	194.37	13.30	5.16	1.36	1.90	3.80	6.24
meningioma cell line:HKBMM	10691-109F7	145.63	46.85	3.08	2.35	0.54	2.17	2.53	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	2.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
merkel cell carcinoma cell line:MS-1	10844-111E7	7.00	2.07	0.00	0.00	0.26	0.26	0.00	0.26
mesenchymal precursor cell - adipose, donor1	11747-123G1	126.74	71.81	3.22	0.92	0.00	1.07	0.77	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	117.07	34.54	3.82	1.64	0.18	1.64	0.55	0.73
mesenchymal precursor cell - adipose, donor3	11749-123G3	163.98	84.06	1.24	1.24	0.41	0.83	0.41	0.83
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	134.15	11.52	2.95	2.25	0.28	0.00	0.84	0.00
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	71.83	17.33	1.35	0.19	0.00	0.00	0.58	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	145.06	16.66	1.39	4.86	0.00	0.00	0.00	0.69
mesenchymal precursor cell - cardiac, donor1	11752-123G6	145.55	42.91	3.60	1.37	0.17	2.06	0.51	1.37
mesenchymal precursor cell - cardiac, donor2	11753-123G7	141.58	44.63	3.34	1.27	0.23	0.69	0.58	1.04
mesenchymal precursor cell - cardiac, donor3	11754-123G8	109.29	36.08	3.32	0.80	0.66	0.40	0.27	0.80
mesenchymal precursor cell - cardiac, donor4	11755-123G9	73.87	11.34	2.70	0.81	0.27	0.14	0.00	0.00
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	51.21	14.08	2.13	0.71	0.28	0.85	0.28	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	92.55	15.48	1.65	0.99	0.66	2.96	0.33	1.32
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	63.37	15.50	1.38	0.28	0.28	0.83	0.00	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	108.91	13.27	2.44	0.35	0.35	0.00	0.35	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	56.15	10.00	1.43	0.20	0.20	0.20	0.20	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	57.87	9.35	1.08	0.36	0.00	1.08	0.00	0.00
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	81.41	10.55	3.00	0.31	0.41	0.21	0.10	0.21
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	57.00	15.28	3.19	0.91	0.46	0.91	0.00	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	99.85	17.62	3.78	1.26	0.84	0.42	0.84	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	88.62	10.76	0.60	0.60	0.75	0.45	0.15	0.15
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	112.30	22.32	2.89	1.14	0.18	1.40	0.44	0.26
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	138.06	18.41	2.21	2.95	1.10	0.74	1.10	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	72.97	12.59	2.86	0.86	0.00	0.29	0.86	0.29
mesenchymal stem cell line:Hu5/E18	10568-108B1	46.31	3.79	0.42	1.26	0.84	0.42	0.00	0.42
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	91.33	22.83	1.83	0.00	0.00	0.00	0.00	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	92.34	17.65	3.58	0.51	1.02	0.26	0.00	0.51
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	106.53	19.37	2.36	0.52	0.26	0.00	0.00	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	124.78	19.41	2.77	1.23	0.00	0.00	0.31	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	110.85	14.36	2.82	1.18	0.47	0.00	0.94	0.71
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	125.57	17.26	4.06	1.02	0.34	0.34	0.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	140.68	17.68	2.36	1.18	0.00	0.00	0.79	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	141.80	19.46	3.71	2.32	0.00	0.00	0.46	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	0.00	48.30	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	202.47	25.96	4.61	1.44	0.29	0.29	0.29	0.58
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	179.37	24.54	4.02	1.34	0.00	0.00	0.67	0.22
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	190.12	26.92	6.49	2.16	0.24	0.24	0.24	0.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	195.80	19.07	5.87	0.00	0.00	0.00	0.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	153.73	12.08	4.70	2.35	0.34	0.34	0.34	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	186.68	18.83	7.37	2.87	0.00	0.00	1.23	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	179.98	27.49	3.87	0.86	0.00	0.00	0.43	1.72
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	194.14	30.08	0.00	0.00	0.00	0.00	0.00	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	129.12	15.49	5.16	0.00	0.00	0.00	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	154.27	28.26	4.87	2.92	0.00	0.00	0.32	1.62
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	178.96	23.28	2.91	0.00	0.00	0.00	1.45	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	155.13	34.12	3.73	1.60	0.00	1.07	0.53	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	130.03	32.71	4.91	1.64	0.00	0.82	0.00	0.82
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	124.00	30.32	3.50	2.33	0.39	0.00	0.39	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	165.80	41.97	4.20	2.10	0.00	2.10	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	146.04	29.80	1.99	0.00	0.00	0.00	0.99	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	109.65	28.60	0.00	0.00	0.00	0.00	4.77	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	114.44	33.21	4.15	2.37	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	87.73	30.46	2.44	1.22	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	108.21	27.05	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	96.91	42.44	3.17	0.63	0.00	0.00	2.53	0.63
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	83.12	39.66	3.10	1.03	0.34	0.34	0.34	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	83.82	55.88	0.00	0.00	0.00	0.00	4.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	79.84	47.90	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	89.54	58.55	6.89	3.44	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	96.16	52.16	4.89	1.63	0.00	0.00	2.04	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	84.21	55.61	3.18	1.59	1.59	0.00	2.38	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	122.03	65.44	1.77	1.18	1.18	0.00	1.18	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	128.73	64.52	4.36	0.00	0.62	0.00	0.94	0.31
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	125.65	64.16	5.35	1.34	0.00	0.00	1.34	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	109.99	44.94	2.37	1.18	2.37	0.00	1.18	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	128.40	61.63	5.14	2.57	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	126.66	62.64	3.44	2.07	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	54.92	7.42	3.96	1.98	0.00	0.00	0.00	0.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	51.59	5.61	1.12	1.12	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	54.07	9.54	3.82	1.27	1.27	0.00	1.27	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	38.28	5.24	2.42	0.40	0.00	0.00	0.40	0.40
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	37.07	6.54	2.18	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	36.74	5.07	1.27	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	27.92	1.82	0.61	0.61	0.00	0.61	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	13.56	0.00	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	27.18	4.12	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	36.71	6.15	1.59	0.20	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	34.72	10.38	2.27	0.00	0.00	0.00	0.32	0.32
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	55.01	6.11	3.06	0.00	1.02	0.00	0.00	0.00
mesodermal tumor cell line:HIRS-BM	10696-109G3	26.31	2.32	2.32	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:ACC-MESO-1	10493-107B7	125.92	21.50	8.98	1.42	1.18	0.71	0.00	0.71
mesothelioma cell line:ACC-MESO-4	10494-107B8	71.12	19.46	1.16	0.70	1.16	1.62	0.23	0.46
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	158.12	72.65	4.27	8.55	0.00	4.27	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	124.94	39.76	4.62	0.41	1.85	0.92	1.13	0.41
mesothelioma cell line:Mero-25	10850-111F4	196.77	125.05	5.22	2.04	1.36	1.13	1.59	1.36
mesothelioma cell line:Mero-41	10851-111F5	149.13	25.67	3.18	0.98	0.00	0.98	0.73	0.98
mesothelioma cell line:Mero-48a	10852-111F6	65.54	6.64	1.77	0.00	0.22	0.22	0.22	0.22
mesothelioma cell line:Mero-82	10853-111F7	310.37	125.10	12.09	4.20	2.10	0.53	1.58	2.89
mesothelioma cell line:Mero-83	10854-111F8	145.20	77.96	4.60	1.70	1.19	1.19	0.85	1.02
mesothelioma cell line:Mero-84	10855-111F9	124.36	55.10	5.56	1.01	0.51	0.00	1.01	0.76
mesothelioma cell line:Mero-95	10856-111G1	146.59	31.06	6.00	1.86	0.62	0.83	1.45	0.62
mesothelioma cell line:NCI-H2052	10847-111F1	218.49	30.31	8.61	2.15	1.33	0.66	0.99	0.99
mesothelioma cell line:NCI-H226	10846-111E9	120.72	28.42	4.52	1.45	0.72	0.90	0.18	0.72
mesothelioma cell line:NCI-H2452	10848-111F2	99.93	16.57	3.25	1.37	0.51	1.37	0.51	0.51
mesothelioma cell line:NCI-H28	10845-111E8	148.10	42.50	6.36	1.27	0.25	0.25	0.76	1.53
mesothelioma cell line:No36	10857-111G2	106.99	36.53	1.63	0.33	0.33	0.65	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	119.49	18.15	2.17	1.35	0.54	0.27	1.08	0.54
migratory langerhans cells, donor1	11901-125F2	0.58	0.19	0.19	0.00	0.00	0.00	0.00	0.19
migratory langerhans cells, donor2	11902-125F3	2.20	0.37	0.12	0.12	0.00	0.00	0.12	0.00
migratory langerhans cells, donor3	11903-125F4	1.08	1.08	0.18	0.18	0.00	0.00	0.00	0.18
mixed mullerian tumor cell line:HTMMT	10689-109F5	47.67	4.57	1.31	0.65	0.00	0.00	0.65	0.65
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	118.26	7.42	4.03	0.64	1.70	2.76	0.00	0.85
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	252.47	35.94	2.76	1.15	0.00	0.92	0.46	0.69
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	120.26	11.42	0.38	0.76	0.57	1.52	0.38	1.14
myelodysplastic syndrome cell line:SKM-1	10772-110F7	880.53	182.02	6.10	5.91	10.53	7.39	3.70	2.22
myeloma cell line:PCM6	10474-106I6	163.67	119.00	1.78	1.19	0.79	2.17	1.38	0.99
myxofibrosarcoma cell line:MFH-ino	10600-108E6	207.99	41.60	0.00	0.51	1.01	0.51	2.54	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	241.06	10.59	3.14	0.39	2.55	3.53	0.78	0.39
nasal epithelial cells, donor1, tech_rep1	12226-129F3	189.20	97.27	2.45	0.33	1.23	1.45	0.67	0.45
nasal epithelial cells, donor1, tech_rep2	12226-129F3	205.03	89.87	2.13	0.59	0.74	1.25	0.59	0.29
nasal epithelial cells, donor2	12227-129F4	221.90	113.16	2.21	0.55	1.10	0.55	1.10	0.55
neuroblastoma cell line:CHP-134	10508-107D4	5.06	1.15	0.00	0.23	0.00	0.69	0.00	0.00
neuroblastoma cell line:NB-1	10539-107G8	0.00	0.19	0.00	0.00	0.00	0.00	0.00	0.00
neuroblastoma cell line:NBsusSR	10607-108F4	237.46	225.86	2.53	1.90	4.01	4.64	2.74	1.69
neuroblastoma cell line:NH-12	10555-107I6	2.80	0.19	0.00	0.00	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	130.47	118.14	4.98	1.42	1.90	2.61	0.47	1.90
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	273.52	190.06	8.71	3.01	2.22	2.69	2.53	3.80
neuroectodermal tumor cell line:TASK1	10774-110F9	504.56	268.48	17.11	1.81	1.61	6.64	2.82	2.62
neuroepithelioma cell line:SK-N-MC	10728-110A8	606.52	194.54	11.44	1.27	2.54	5.72	0.64	2.54
neurofibroma cell line:Hs 53.T	10729-110A9	152.78	37.80	3.73	0.80	0.00	1.06	0.80	1.06
neutrophil PMN, donor1	12133-128D9	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	578.73	559.45	3.38	2.54	6.93	4.23	3.72	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	220.14	64.84	10.41	0.80	0.80	1.60	0.00	0.80
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	160.30	33.98	7.05	1.92	0.64	0.32	1.60	0.96
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	20.76	2.63	2.63	0.26	0.00	0.00	0.26	0.00
nucleus accumbens, adult, pool1	10037-101F1	8.72	1.31	0.56	0.28	0.00	0.00	0.09	0.09
occipital cortex - adult, donor10196	10172-103C1	30.91	0.00	0.00	2.06	0.00	0.00	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	29.52	1.88	0.00	0.27	0.00	0.00	0.00	0.00
occipital cortex, newborn, donor10223	10355-105E4	48.77	9.46	0.00	1.46	1.09	2.91	1.46	0.00
occipital lobe, adult, donor1	10076-102A4	7.61	0.26	0.00	0.52	0.00	0.00	0.00	0.00
occipital lobe, fetal, donor1	10073-102A1	33.47	8.15	1.29	0.86	0.00	1.72	1.29	0.86
occipital pole, adult, pool1	10036-101E9	9.78	0.47	0.39	0.08	0.00	0.08	0.00	0.00
olfactory region, adult	10195-103E6	7.83	0.57	0.19	0.19	0.00	0.00	0.00	0.00
optic nerve, donor1	10277-104E7	18.01	4.00	0.00	0.00	0.00	2.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	289.10	162.43	6.26	2.73	3.42	6.15	1.25	2.16
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	492.12	330.14	4.53	2.47	7.97	9.75	0.96	0.82
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	150.70	22.69	2.54	2.54	0.51	0.85	1.19	1.52
oral squamous cell carcinoma cell line:SAS	10544-107H4	964.96	179.96	6.01	4.62	4.16	3.47	3.70	2.54
osteoclastoma cell line:Hs 706.T	10704-109H2	40.57	6.47	1.18	0.59	0.00	0.00	0.00	0.00
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	53.26	5.61	0.00	0.00	0.00	0.93	0.00	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	343.11	81.01	14.00	3.18	3.39	2.76	1.06	3.39
ovary, adult, pool1	10020-101D2	173.65	20.09	5.15	1.66	0.26	0.00	0.70	1.48
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	77.36	8.98	1.28	0.37	0.37	0.18	0.37	0.37
pancreas, adult, donor1	10049-101G4	266.20	37.63	2.82	0.94	0.00	0.00	0.94	0.94
pancreatic carcinoma cell line:NOR-P1	10698-109G5	82.74	28.51	3.35	0.56	0.00	0.00	0.84	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	206.13	78.70	8.52	3.92	0.85	1.87	3.75	2.73
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	101.50	21.36	1.49	0.66	0.99	0.17	0.17	0.00
paracentral gyrus, adult, pool1	10035-101E8	9.88	0.27	0.27	0.37	0.00	0.00	0.00	0.00
parietal cortex, adult, donor10258	10373-105G4	57.25	0.73	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe - adult, donor10196	10171-103B9	24.45	1.88	0.00	0.00	0.00	0.00	0.00	0.00
parietal lobe, adult, donor10252	10157-103A4	11.97	1.14	0.00	0.29	0.29	0.29	0.00	0.00
parietal lobe, adult, pool1	10034-101E7	9.52	0.70	0.35	0.53	0.00	0.00	0.00	0.00
parietal lobe, fetal, donor1	10072-101I9	36.85	9.70	0.97	0.00	0.00	1.94	0.00	0.00
parietal lobe, newborn, donor10223	10356-105E5	63.18	10.47	0.75	1.50	3.74	3.36	1.12	0.37
parotid gland, adult	10199-103F1	54.88	5.55	2.47	1.23	0.00	0.00	0.62	0.62
penis, adult	10200-103F2	76.27	6.98	1.07	0.54	0.00	0.00	1.61	0.00
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	321.11	134.62	7.81	2.79	2.42	3.35	1.67	0.93
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	153.71	17.92	4.08	1.31	0.00	0.44	0.15	0.15
pineal gland - adult, donor10196	10179-103C8	30.32	7.74	0.00	0.00	0.65	0.00	0.00	1.29
pineal gland, adult, donor10252	10160-103A7	30.80	8.88	0.59	0.59	0.59	0.00	0.59	0.00
pineal gland, adult, donor10258	10377-105G8	22.57	0.63	0.00	0.00	0.00	0.00	0.00	0.00
pituitary gland - adult, donor10196	10180-103C9	18.21	2.02	1.01	0.00	0.00	0.00	0.00	1.01
pituitary gland, adult, donor10252	10162-103A9	75.05	5.21	1.04	0.00	0.00	0.00	0.00	0.00
pituitary gland, adult, donor10258	10378-105G9	14.47	1.70	0.85	0.00	0.00	0.00	0.00	0.00
placenta, adult, pool1	10021-101D3	59.99	12.69	4.62	1.08	0.00	0.00	0.22	0.00
plasma cell leukemia cell line:ARH-77	10840-111E3	430.25	133.49	2.38	3.44	6.09	2.78	0.79	2.65
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	44.36	4.20	3.42	0.62	0.31	0.16	0.00	0.00
pons, adult, pool1	10033-101E6	19.37	1.81	0.69	0.95	0.17	0.17	0.00	0.26
postcentral gyrus, adult, pool1	10032-101E5	8.72	0.96	0.70	0.17	0.00	0.09	0.17	0.09
promyelocytes/myelocytes PMC, donor1	12132-128D8	389.00	127.58	0.00	2.09	0.00	2.09	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	77.11	60.59	0.00	5.51	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	105.62	70.41	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	114.20	20.98	8.16	1.60	0.73	0.73	0.29	0.00
prostate cancer cell line:PC-3	10439-106E7	227.42	76.05	5.99	0.54	0.73	0.91	1.45	0.73
prostate, adult, pool1	10022-101D4	93.41	16.78	2.63	0.54	0.09	0.09	0.54	0.63
putamen, adult, donor10196	10176-103C5	13.69	0.94	0.00	0.94	0.00	0.00	0.24	0.00
putamen, adult, donor10252	10152-102I8	11.76	3.92	0.00	0.00	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	40.43	5.46	1.09	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	3.62	0.00	0.24	0.24	0.24	0.00	0.00	0.00
putamen, newborn, donor10223	10365-105F5	52.48	5.25	0.00	0.75	0.75	0.75	0.00	0.75
rectal cancer cell line:TT1TKB	10469-106I1	202.20	91.06	1.45	0.58	0.58	1.16	0.87	0.29
rectum, fetal, donor1	10067-101I4	44.51	20.86	1.39	0.00	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	80.77	10.81	2.12	0.21	0.21	0.64	0.21	0.00
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	66.69	48.46	4.14	0.00	1.24	0.41	0.41	0.83
retina, adult, pool1	10030-101E3	38.87	3.38	1.49	0.50	0.00	0.00	0.30	0.10
retinoblastoma cell line:Y79	10475-106I7	23.12	3.38	0.00	0.00	0.52	1.04	0.26	0.00
rhabdomyosarcoma cell line:KYM-1	10787-110H4	50.04	35.29	2.58	0.61	0.12	0.37	0.25	0.12
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	351.50	152.41	0.84	0.84	0.28	0.00	2.25	0.56
sacrococcigeal teratoma cell line:HTST	10695-109G2	140.96	13.64	1.52	0.00	0.00	0.00	1.52	0.76
salivary acinar cells, donor1	11771-123I7	286.16	266.09	2.91	3.24	1.62	2.91	2.91	1.78
salivary acinar cells, donor2	11772-123I8	276.61	122.95	2.20	3.03	0.41	0.96	1.79	3.17
salivary acinar cells, donor3	11773-123I9	364.13	75.47	1.32	3.31	0.00	0.00	2.65	0.66
salivary gland, adult, pool1	10093-102C3	70.92	2.86	2.29	1.14	0.00	0.00	0.57	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	124.02	40.72	1.18	1.69	1.18	3.12	0.34	0.76
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	105.91	36.32	3.06	1.06	1.88	2.23	0.00	0.35
seminal vesicle, adult	10201-103F3	110.05	10.05	2.12	1.06	0.00	1.06	2.12	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	224.71	27.94	3.64	1.94	0.97	1.70	0.24	1.21
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	98.64	15.85	1.51	1.26	0.25	0.50	0.50	0.50
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	110.39	6.02	1.00	0.00	0.00	0.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	105.04	76.56	2.42	0.27	0.27	0.40	0.27	0.27
signet ring carcinoma cell line:Kato III	10436-106E4	157.28	66.10	1.66	0.77	0.66	1.33	1.55	0.33
signet ring carcinoma cell line:NUGC-4	10483-107A6	156.64	56.13	4.26	0.39	0.13	0.90	1.03	0.39
skeletal muscle - soleus muscle, donor1	10282-104F3	75.19	7.09	0.00	0.71	0.00	0.00	0.00	0.00
skeletal muscle, adult, pool1	10023-101D5	294.45	56.13	2.04	2.28	0.00	0.24	0.48	2.04
skeletal muscle, fetal, donor1	10066-101I3	63.32	22.11	1.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	210.34	13.57	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	131.30	20.20	3.16	1.89	0.63	0.00	2.52	1.89
small cell cervical cancer cell line:HCSC-1	10800-110I8	1.33	0.00	0.00	0.33	0.00	0.00	0.00	0.00
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	387.39	111.27	1.26	4.10	7.88	3.15	2.52	1.26
small cell lung carcinoma cell line:DMS 144	10841-111E4	73.24	49.92	0.39	0.96	0.00	0.19	0.39	0.39
small cell lung carcinoma cell line:LK-2	10541-107H1	502.56	163.51	11.21	1.81	1.48	2.14	1.15	0.66
small cell lung carcinoma cell line:NCI-H82	10842-111E5	1600.94	419.50	22.68	8.36	17.53	24.93	9.65	8.69
small cell lung carcinoma cell line:WA-hT	10562-108A4	0.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
small intestine, adult, pool1	10024-101D6	98.42	13.62	2.03	1.43	0.24	0.60	0.12	2.03
small intestine, fetal, donor1	10064-101I1	71.01	18.67	1.47	0.74	0.00	0.00	0.25	0.25
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	136.43	21.54	1.03	1.54	1.03	3.59	1.03	1.03
smooth muscle, adult, pool1	10048-101G3	90.20	5.94	2.33	0.26	0.00	0.26	0.78	0.52
somatostatinoma cell line:QGP-1	10781-110G7	162.42	15.81	2.14	0.80	0.27	3.75	0.00	0.00
spinal cord - adult, donor10196	10181-103D1	82.59	7.34	0.92	0.69	0.46	0.00	0.23	0.00
spinal cord, adult, donor10252	10159-103A6	45.74	7.49	1.18	1.18	0.39	0.00	0.00	0.00
spinal cord, adult, donor10258	10369-105F9	24.21	0.69	0.69	0.69	0.00	0.00	0.00	0.69
spinal cord, fetal, donor1	10056-101H2	38.42	13.42	1.83	1.22	0.61	0.00	0.00	1.22
spinal cord, newborn, donor10223	10359-105E8	48.22	5.97	0.46	0.00	0.00	0.00	0.00	0.46
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	157.87	12.99	3.58	0.90	0.00	0.45	1.05	0.30
spleen, adult, pool1	10025-101D7	127.09	62.56	3.63	1.21	0.66	0.22	0.88	0.99
spleen, fetal, pool1	10044-101F8	125.54	73.26	3.81	1.59	0.40	0.40	0.40	0.48
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	171.42	56.72	0.52	0.72	1.35	0.93	1.04	0.21
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	216.08	71.39	2.85	1.52	1.90	0.95	1.52	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	26.21	3.15	0.35	0.00	0.00	0.00	0.00	0.00
squamous cell carcinoma cell line:T3M-5	10616-108G4	150.90	9.38	1.17	0.00	1.95	0.39	0.39	0.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	303.91	64.95	3.60	1.80	1.69	3.83	1.80	1.80
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	389.71	112.25	3.81	0.42	1.69	3.39	1.69	1.69
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	217.88	101.96	2.12	0.85	2.96	2.96	0.42	0.00
stomach, fetal, donor1	10062-101H8	60.87	18.16	4.27	0.00	0.00	0.00	0.00	0.00
submaxillary gland, adult	10202-103F4	65.51	7.98	1.71	0.00	0.57	0.00	0.57	0.57
substantia nigra - adult, donor10196	10178-103C7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	34.69	4.78	0.62	0.42	0.00	0.21	0.21	0.00
substantia nigra, adult, donor10258	10371-105G2	11.38	0.52	0.52	0.00	0.00	0.00	0.00	0.00
substantia nigra, newborn, donor10223	10358-105E7	74.19	7.07	0.71	1.41	0.00	1.41	0.00	0.71
synovial sarcoma cell line:HS-SY-II	10441-106E9	133.89	180.66	5.04	1.15	0.23	0.46	2.52	0.69
temporal lobe, adult, pool1	10031-101E4	5.51	0.17	0.08	0.08	0.00	0.17	0.00	0.08
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	19.94	8.55	0.00	2.85	0.00	0.00	0.00	0.00
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	30.33	11.87	0.88	0.88	0.44	1.32	0.00	1.76
tenocyte, donor1	11763-123H8	68.07	18.15	3.49	2.09	0.00	0.35	0.00	0.00
tenocyte, donor2	11765-123I1	68.29	10.30	3.05	1.14	0.00	0.00	0.00	0.00
tenocyte, donor3	11768-123I4	57.45	20.02	4.82	0.37	0.00	0.37	1.11	0.37
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	22.26	15.13	1.02	0.00	0.00	0.00	0.34	0.00
teratocarcinoma cell line:NCR-G1	10798-110I6	14.34	4.62	1.08	0.31	0.00	0.00	0.00	0.15
teratocarcinoma cell line:PA-1	10807-111A6	66.80	30.53	4.49	0.31	0.00	0.00	0.15	0.62
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	31.86	14.09	1.90	0.38	0.00	0.00	0.25	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	54.46	14.37	2.65	0.00	0.00	0.00	0.00	0.00
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	25.52	11.67	1.31	0.22	0.11	0.00	0.11	0.44
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	38.43	14.01	0.65	0.65	0.00	0.00	0.00	0.33
testis, adult, pool1	10026-101D8	126.48	14.28	5.80	1.18	0.11	0.00	0.54	1.50
testis, adult, pool2	10096-102C6	103.75	9.02	2.26	0.90	0.45	0.45	0.00	0.00
thalamus - adult, donor10196	10168-103B6	110.40	4.42	2.21	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10252	10154-103A1	25.32	3.13	0.94	0.00	0.00	0.00	0.16	0.00
thalamus, adult, donor10258, tech_rep1	10370-105G1	33.87	3.08	0.00	1.54	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	6.26	0.33	0.00	0.16	0.16	0.00	0.00	0.00
thalamus, newborn, donor10223	10366-105F6	28.19	2.30	0.00	0.00	0.00	0.58	0.58	0.58
throat, adult	10209-103G2	106.11	12.73	1.50	1.00	0.00	0.25	0.75	0.50
throat, fetal, donor1	10061-101H7	39.61	15.24	1.83	0.00	0.30	0.00	0.00	0.30
thymic carcinoma cell line:Ty-82	10803-111A2	351.36	669.13	1.19	3.78	5.56	3.97	2.19	2.78
thymus, adult, pool1	10027-101D9	152.50	69.29	4.77	1.39	0.80	0.80	0.70	2.09
thymus, fetal, pool1	10043-101F7	106.71	47.80	4.99	1.04	3.12	0.94	0.42	0.31
thyroid carcinoma cell line:KHM-5M	10776-110G2	133.49	11.17	1.86	0.80	0.53	1.60	0.80	0.53
thyroid carcinoma cell line:TCO-1	10783-110G9	68.87	11.73	2.79	0.28	0.42	0.28	0.28	0.14
thyroid, adult, pool1	10028-101E1	47.50	6.53	2.15	0.19	0.00	0.00	0.00	0.75
thyroid, fetal, donor1	10060-101H6	58.27	12.13	0.79	0.26	0.00	0.00	0.53	0.26
tongue epidermis (fungiform papillae), donor1	10288-104F9	120.11	21.56	0.00	3.08	0.00	3.08	0.00	0.00
tongue, adult	10203-103F5	195.13	25.12	3.02	1.63	0.23	0.00	1.63	2.33
tongue, fetal, donor1	10059-101H5	109.56	24.83	3.55	2.36	0.39	0.39	1.18	1.18
tonsil, adult, pool1	10047-101G2	145.35	26.15	5.71	1.10	0.50	0.30	0.20	0.30
trachea, adult, pool1	10029-101E2	145.27	31.41	3.84	1.06	0.00	0.00	0.16	1.15
trachea, fetal, donor1	10058-101H4	66.55	18.85	1.92	0.77	0.38	0.00	1.15	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	110.18	21.61	2.13	0.71	0.00	0.00	0.35	0.35
transitional-cell carcinoma cell line:5637	10418-106C4	254.20	58.97	1.62	1.32	2.94	4.86	0.61	0.20
transitional-cell carcinoma cell line:JMSU1	10492-107B6	647.74	303.97	12.85	6.11	3.45	6.11	5.64	4.70
tridermal teratoma cell line:HGRT	10694-109G1	91.32	11.42	5.71	0.00	0.00	0.00	0.00	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	81.69	72.46	5.16	0.85	0.51	0.93	0.85	0.34
umbilical cord, fetal, donor1	10057-101H3	54.25	8.35	2.09	2.09	0.00	0.00	2.09	0.00
uterus, adult, pool1	10100-102D1	142.13	17.40	3.24	0.51	0.00	0.00	0.51	0.34
uterus, fetal, donor1	10055-101H1	61.43	28.16	8.70	0.51	0.00	0.00	1.02	0.00
vagina, adult	10204-103F6	138.29	31.66	1.94	0.65	0.00	0.00	0.65	1.94
vein, adult	10191-103E2	138.53	28.93	1.97	2.85	0.22	0.00	0.66	1.10
xeroderma pigentosum b cell line:XPL 17	10563-108A5	157.82	66.49	0.80	0.53	0.53	1.34	0.27	0.00